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CHAPTER I 
 
INTRODUCTION 
 
Thesis Overview 
 The experiments described in this thesis were designed to elucidate the role that 
stress granule formation plays in respiratory syncytial virus (RSV) infection. In Chapter I, 
I provide a brief background of RSV, host stress granules, and interactions between RSV 
and the innate immune system. In Chapter II, I present my research examining the 
kinetics of stress granule formation during RSV infection. I demonstrate that stress 
granules form during RSV infection and they may play an important role in viral 
replication. In Chapter III, I examine the upstream signaling pathways utilized by RSV to 
initiate stress granule formation. I show that RSV infection induces the activation of 
PKR, which in turn phosphorylates eIF2α and is responsible stress granules formation. I 
then show that reduction of PKR protein levels by shRNA does not affect RSV 
replication. However, the PKR inhibitor, 2-aminopurine, significantly impairs RSV 
replication. Chapter IV summarizes our observations and offers potential future 
experiments that will be useful to continue this work.  
 
Respiratory syncytial virus 
Human respiratory syncytial virus (RSV) represents a leading cause of serious 
lower respiratory tract illness in infants, the elderly, and immunocompromised 
individuals worldwide. First discovered in 1956, the virus remains a prime target for 
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vaccine development due to the frequency of infection and the potential for severe 
disease. Disease associated with RSV infection ranges from mild to severe and typical 
symptoms include runny nose, fever, and coughing while in more severe cases wheezing 
and difficulties in breathing may occur 
RSV belongs to the subfamily Pneumovirinae of the Paraxmyxoviridae family 
and is a member of the Mononegavirales order. The virion consists of a host-derived lipid 
membrane containing three virally derived surface proteins that surrounds the viral 
nucleocapsid. Viral particles are typically observed as small pleomorphic particles around 
200 nm in diameter, or as long filamentous particles reaching up to 10 µM in length 
(Roberts et al., 1995). An illustration of a virion particle can be found in Figure 1-1. 
The RSV genome comprises 15,222 bases that encode nine structural and two 
nonstructural proteins. The two nonstructural proteins, NS1 and NS2, function as 
interferon antagonists. The viral genome, nucleoprotein (N), phosphoprotein (P), and 
polymerase protein (L) assemble to form the viral ribonucleoprotein complex that is 
responsible for transcription of viral genes and replication of the viral genome. The 
glycoprotein (G) and fusion protein (F) are virion surface proteins responsible for  
attachment and entry of the virion into host cells, respectively (Levine et al., 
1987). The small hydrophobic (SH) protein is also expressed on the surface of virion 
particles and has been predicted to function in enhancing membrane permeability (Carter 
et al., 2010). The matrix (M) protein is found inside the virion particle and is necessary 
for particle morphogenesis. Finally, the M2-1 and M2-2 proteins play important roles in 
transcription processivity and replication initiation, respectively (Fearns and Collins, 
1999) (Bermingham and Collins, 1999). See Table 1-1 for a list of the viral proteins 
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Figure 1-1. The RSV virion. RSV surface proteins (G, SH, and F) are shown on the 
membrane of the particle while the internal proteins associate with the genome. Figure 
provided by Tom Utley.  
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and their functions. 
The first step in the viral life cycle involves the virion particle attaching to host 
cells through an interaction between the viral G protein and cellular glycosaminoglycans, 
particularly heparan sulfate and chondroitin sulfate B (Feldman et al., 2000). RSV F then 
mediates fusion between the virion envelope and the plasma membrane. Following 
fusion, the nucleocapsid is released into the cytoplasm where transcription of viral genes 
begins using the RNA-dependent viral RNA polymerase. Transcription occurs in a polar 
gradient with genes proximal to the 3´ terminus of the genome produced in greater 
abundance than those located closer to the 5´ terminus. Transcription and translation of 
viral proteins likely begins immediately upon release of the nucleocapsid into the 
cytoplasm. In contrast, replication of the viral genome is delayed following infection. The 
three surface proteins are glycosylated and can be detected within the endoplasmic 
reticulum and Golgi apparatus as well as at the plasma membrane. The N, P, L, M, and 
M2-1 proteins localize to cytoplasmic viral inclusion bodies. Figure 1-2 is a confocal 
image showing inclusion bodies and filaments in RSV infected cells. 
For replication to occur, the RNA-dependent viral RNA polymerase must produce 
an antigenomic intermediate that is then used as a template for progeny genomes. The 
components of the virion assemble at the host plasma membrane and budding of new 
infectious virions occurs. In polarized cells, assembly and budding occur exclusively at 
the apical surface of infected cells. Interestingly, the majority of newly formed particles 
do not bud from the host cell but instead remain cell associated. Figure 1-3 provides an 
illustration of the viral life cycle. 
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Table 1-1. The RSV proteins and their functions. 
 6	  
Interactions between RSV and cellular proteins 
 The interactions between host proteins and RSV proteins have thus far been 
poorly defined. Multiple proteins have been shown to bind or colocalize with RSV 
proteins; however, the exact functions or roles for the majority of these proteins on 
infection are unknown. The chaperone protein heat shock protein 70 (HSP70) colocalizes 
with viral inclusion bodies during infection. Additionally, an interaction between the viral 
polymerase complex and HSP70 was demonstrated through immunoprecipitation (Brown 
et al., 2005). Another HSP, HSP90, colocalizes with RSV F in viral filaments. In 
experiments in which HSP90 expression of function was inhibited, RSV transmission and 
filament formation were reduced, suggesting HSP90 is important in either viral assembly 
or egress (Radhakrishnan et al., 2010). The Rab11a family interacting protein 2 (Rab11-
FIP2) is essential for proper RSV budding. Deletion of the N-terminal C2 domain 
resulted in a block to viral egress and the wild-type protein colocalized with viral 
inclusion bodies and viral filaments (Utley et al., 2008). In addition to Rab11-FIP2, the 
integral membrane protein caveolin-1 is known to associate with viral particles (Brown et 
al., 2002).  
Experiments examining RNA transcription in vitro indicate that the cellular 
cytoskeleton protein actin is important for viral transcription (Burke et al., 1998).When 
chemical inhibitors of actin or microtubule assembly were used, viral egress and budding 
were negatively affected, respectively (Kallewaard et al., 2005). Inhibition of the actin-
associated protein, profilin, also resulted in a decrease in viral transcription (Burke et al., 
2000). Actin also associates with viral inclusion bodies (Brown et al., 2005). Actin binds 
the N protein-encapsidated viral RNA, and profilin then binds the actin-RNA structure. 
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Figure 1-2. Confocal images of the major RSV structures in infected cells. Cells were 
infected with RSV (MOI=5.0) for 48 hours. Cells were fixed and processed for 
immunofluorescence. (A) Anti-RSV P (green in merge) was used to detect viral inclusion 
bodies and anti-RSV F (red in merge) was used to detect viral filaments. A fluorescent 
dye was used to stain the nuclei (blue in merge). (B) The inset from (A) showing a close-
up of viral filaments. The collapsed Z-sections are shown for each image. 
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Figure 1-3. Diagram of the RSV life cycle.  (1) The RSV virion attaches to the cell.  (2) 
The viral ribonucleoprotein complex is delivered to the cytoplasm.  (3) The genome is 
transcribed into viral mRNAs, which are then translated on host ribosomes (4) either at 
the endoplasmic reticulum for the glycoproteins, or free cytoplasmic ribosomes.  (5) A 
switch occurs from transcription to replication of the viral genome.  (6) glycoproteins are 
trafficked from the ER to the Golgi apparatus where they are modified. (7) All the virion 
components must be trafficked to the apical membrane.  (8) Assembled virions bud from 
the infected cell. Image provided by Tom Utley. 
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Interestingly, deletion of the divalent-cation-binding domain of actin resulted in an 
inhibition of viral transcription. Deletion mutants where the functional domains necessary 
for actin polymerization were removed had no effect on RSV transcription (Harpen et al., 
2009). These results show that while actin is a critical protein for cytoskeletal 
rearrangement, its importance in RSV gene transcription is independent of this role. 
The cellular GTPase, RhoA, was identified as a potential interacting partner with 
RSV F by yeast two-hybrid and immunoprecipitation studies. RhoA has a function in 
cytoskeletal reorganization and cell motility, among other processes. Overexpression of 
RhoA in stably transfected cells increases syncytium formation upon RSV infection 
(Pastey et al., 1999). RSV infection induces activation of RhoA as well as relocalization 
of the protein to the plasma membranes of infected cells (Gower et al., 2001). Treatment 
with specific inhibitors of RhoA signaling during viral infection results in reduced 
syncytia formation as well as altered morphology of viral filaments. Interestingly, in 
RhoA inhibitor treated cells, RSV titers were unaffected, suggesting that RhoA signaling 
is not necessary for efficient viral replication (Gower et al., 2005). In addition to RhoA, 
phosphatidyl-3-kinase (PI3K) and Rac1 appear to be important in viral filament 
formation, as treatment with inhibitors to either of these molecules resulted in altered 
filament morphology during infection (Jeffree et al., 2007). 
 
Stress granules 
Stress granules are host RNA cytoplasmic granules formed in cells in response to 
multiple types of environmental stress (Kedersha and Anderson, 2007). The most fully 
characterized pathway for stress granule formation involves phosphorylation of the 
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translation initiation factor eIF2α, leading to accumulation of stalled translation pre-
initiation complexes (Kedersha et al., 1999). Untranslated RNA transcripts are bound by 
mRNA-binding proteins, such as TIA-1, G3BP, and HuR. Translation factors such as 
eIF4E and eIF3 are recruited to stress granules, resulting in protein-RNA complexes that 
are the contents of the granules (Kedersha and Anderson, 2007). Stress granules can also 
be induced by an alternate mechanism that is independent of eIF2α phosphorylation via 
inactivation of the translation factors eIF4A or eIF4G (Dang et al., 2006) and (Mokas et 
al., 2009).  Figure 1-4 shows confocal images of cells mock-treated or treated with a 
cellular stressor, sodium arsenite, and stained for stress granules. 
eIF2α phosphorylation is mediated by four known kinases: protein kinase R 
(PKR), PKR-like ER-localized eIF2α kinase (PERK), general control nonrepressed 2 
(GCN2) kinase, and heme-regulated inhibitor (HRI). Each kinase is activated in response  
to a specific stress. PKR is activated by the presence of double-stranded RNA 
intermediates during viral infection. PERK is activated during ER stress, typically by the 
unfolded protein response. GCN2 is typically activated in response to amino acid 
deprivation and HRI is activated by low intracellular heme levels.  
There is much debate about the function of stress granules. Compositionally, stress 
granules are made up of untranslated mRNA, mRNA-binding proteins, and translation 
factors. Originally it was proposed that stress granules function as an mRNA sorting 
facility, targeting mRNAs for degradation, storage, or translation reinitiation (Anderson 
and Kedersha, 2002).  However, live-cell imaging analysis of mRNAs revealed that a 
given mRNA only spends a short amount of time, generally less than a minute, in a stress 
granule. In addition, the vast majority of translationally repressed mRNA in cells remains 
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Figure 1-4. Stress granule formation in response to sodium arsenite. HEp-2 cells 
were mock treated (top row) or arsenite treated (bottom row) for 30 minutes. Cells then 
were stained for the stress granule markers G3BP (green in merge) or TIA-1 (red in 
merge). 
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 cytoplasmic (Mollet et al., 2008).  These data suggest stress granules do not modify or 
store mRNA. Another possibility is that stress granules are important for delaying 
apoptosis. A number of apoptotic regulatory factors are found in stress granules and cells 
that are for impaired stress granule formation exhibit faster rates of apoptosis induction 
after stress (Arimoto et al., 2008), (Ohn et al., 2008), (Eisinger-Mathason et al., 2008), 
(Kolobova et al., 2009), and (Buchan and Parker, 2009).  
 
Virus and stress granule interactions. 
Many viruses are known to modulate host translation in order to facilitate viral 
protein production.  In recent years several viruses have been studied to monitor their 
effect on the host stress response. Viruses known to induce host stress granules include 
the paramyxovirus Sendai virus, the coronavirus mouse hepatitis virus, the alphavirus 
Semliki Forest virus, reovirus, and poliovirus (Iseni et al., 2002), (McInerney et al., 
2005), (Raaben et al., 2007), (Smith et al., 2006), and (White et al., 2007). In addition, 
West Nile virus prevents stress granule formation throughout infection (Emara and 
Brinton, 2007).  While it is reasonable to think that stress granules may play a role in 
infection for these viruses, the specific role or function of stress granules during infection 
has not been well defined.  
Specific strains of mammalian orthoreovirus can induce stress granule formation 
both early (Qin et al., 2009) and late times after infection (Smith et al., 2006). Using a 
non-phosphorylatable eIF2α mutant expressing cell line, it was shown that eIF2α 
phosphorylation is essential for stress granule formation following reovirus infection. 
Interestingly, in experiments using PKR -/-, PERK -/-, HRI -/- and GCN2 -/- mouse 
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embryo fibroblast (MEF) cell lines, reovirus infection continued to induce stress 
granules, indicating that at least two of these kinases are activated by reovirus during 
infection and are responsible for stress granule formation (Qin et al., 2009).  
 Poliovirus induces stress granules as early as two hours post-infection, with many 
infected cells staining positively for stress granules (Mazroui et al., 2006) and (White et 
al., 2007). These reports, using G3BP as a marker for stress granules, appeared to show 
that although poliovirus induced stress granules at early times post infection, cleavage of 
G3BP mediated by a viral protease prevented stress granule formation at later times after 
infection (White et al., 2007). Subsequent characterization of this process revealed that 
although several stress granule proteins are degraded during poliovirus infection, stress 
granules that stain positively for TIA-1 can be found in infected cells throughout the 
course of infection, with as many as 90% of infected cells staining positively for stress 
granules at 6 hours post-infection (Piotrowska et al., 2010).  
Stress granule proteins can interact directly with viral processes. Sindbis virus and 
vaccinia virus recruit the stress granule protein G3BP to viral structures (Cristea et al., 
2006) and (Katsafanas and Moss, 2007) while West Nile virus interacts with the host 
stress granule proteins TIA-1 and TIAR (Emara and Brinton, 2007). Sendai virus trailer 
RNA binds TIAR (Iseni et al., 2002), and the poliovirus 3C proteinase can cleave G3BP 
(White et al., 2007). HuR associates with regions of the hepatitis C virus RNA and the 
human immunodeficiency virus reverse transcriptase (Rivas-Aravena et al., 2009) and 
(Spangberg et al., 2000). 
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PKR signaling 
PKR is a well-characterized protein kinase that is activated by double-stranded 
RNA (dsRNA) during viral infection and often is associated with antiviral host cell 
responses. Upon binding to dsRNA, PKR dimerizes and autophosphorylates, resulting in 
an active state of the protein (Garcia et al., 2007). As previously mentioned, 
phosphorylated PKR is one of the four known kinases that regulates the activation of the 
translation initiation factor eukaryotic initiation factor 2 (eIF2α). Phosphorylated eIF2α is 
not able to mediate the delivery of initiator Met-tRNA to host translation complexes, 
resulting in a reduction of protein synthesis in virus-infected cells.  
In addition to eIF2α phosphorylation, PKR plays a role in a number of other host 
signaling pathways. Most of these studies have been carried out in MEF cells that lack 
PKR expression (PKR -/- MEF). PKR -/- MEFs are deficient in activation of the MAP 
kinases JNK and p38 in response to a number of cellular stresses (Goh et al., 2000). 
STAT1 activation is impaired in PKR -/- MEFs in response to interferon treatment 
(Ramana et al., 2000).  PKR binds directly to the tumor suppressor p53 (Cuddihy et al., 
1999) and PKR knockdown cells are more prone to tumor formation (Yoon et al., 2009). 
PKR also plays an important role in NF-κB activation in response to viral infection. PKR 
appears to stabilize the IKK complex which is essential for allowing  NF-κB to 
translocate to the nucleus (Garcia et al., 2006). 
Many viruses have evolved molecular mechanisms to prevent PKR activation, 
presumably in order to inhibit the type I interferon response or to ensure host translation 
machinery remains sufficiently active for synthesis of viral proteins. Viral strategies to 
prevent PKR activation include expression of viral products that interact directly with 
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PKR and prevent activation, expression of viral proteins that bind and sequester dsRNA, 
or activation of host proteins that inhibit or counteract PKR activation (Garcia et al., 
2007). In virtually every case studied to date, the activation of PKR in infected cells is 
associated with induction of an antiviral state. However, activation of PKR during 
hepatitis C virus (HCV) infection may enhance viral replication because of the resulting 
lack of translation of specific antiviral interferon-stimulated genes during infection 
(Garaigorta and Chisari, 2009).  
RSV infection leads to increased levels of expression of total PKR. RSV infection 
also can induce the phosphorylation and activation of PKR (Groskreutz et al., 2010).  
These studies also suggest a direct interaction between PKR and the RSV nucleoprotein 
(N) 
Induction of PKR is often associated with an antiviral state. For example, both 
vesicular stomatitis virus and influenza virus grew to higher viral titers in PKR-/- mice in 
comparison to wild-type mice (Balachandran et al., 2000). Similarly, PKR-/- mice 
exhibited faster mortality rates when infected with Bunyamwera virus in comparison to 
wild-type mice (Streitenfeld et al., 2003). There are cases, however, in which PKR plays 
only a minor or no role in inhibition of replication. Severe acute respiratory syndrome 
coronavirus replication is unaffected in cells that had been treated with 
phosphorodiamidate morpholino oligomers (PMO) specific for PKR mRNA (Krahling et 
al., 2009).  In cells treated with siRNA for PKR, adenovirus or reovirus replication 
(Zhang and Samuel, 2007), or rotavirus protein translation (Rojas et al., 2010), is 
unaffected. Likewise, Rift Valley fever virus replication was not altered in PKR -/- MEFs  
(Habjan et al., 2009).  
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Innate immune signaling during RSV infection 
 As previously mentioned, infection with RSV can result in severe lower 
respiratory tract disease. A significant portion of disease is thought to be due to improper 
activation of the innate immune system during infection. Currently, RSV is known to 
both activate and inactivate several key signaling pathways involved in early viral 
detection. 
Toll-like receptors (TLR) function to recognize general viral or bacterial markers 
and are expressed on a variety of respiratory epithelial cells. TLR activation is essential 
for rapid activation of the innate immune response. However, improper TLR signaling 
can result in acute or chronic lung inflammation (Lafferty et al., 2010). RSV is known to 
upregulate TLR4 expression and membrane localization in airway epithelial cells after 
infection. Increased expression of TLR4 then results in greater sensitivity to endotoxin in 
comparison to uninfected cells (Monick et al., 2003). IL-6 and IL-8 expression are also 
increased as a result of TLR4 upregulation, implicating this pathway as a major cause of 
disease during infection (Xie et al., 2009). Other studies have shown that expression of 
RSV F alone can mediate the upregulation of TLR4 (Kurt-Jones et al., 2000). 
Interestingly, severe respiratory disease has been linked to two polymorphisms of TLR4.  
Infants expressing an Asp299Gly or Thr399Ile mutation in TLR4 exhibited a much 
greater risk of severe RSV bronchiolitis (Tal et al., 2004) and (Awomoyi et al., 2007). 
In addition to TLR4, TLR3 and TLR2 are activated in RSV-infected cells. 
Expression of TLR3 is increased in RSV infected cells, likely due to the presence of viral 
dsRNA intermediate products. TLR3 also undergoes a change in subcellular localization, 
switching from primarily being localized to endosomal membranes to being found at the 
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plasma membrane of infected cells. Subsequent exposure to dsRNA resulted in increased 
NF-κB activation and IL-8 production, suggesting that RSV primes epithelial cells for 
hyperreactivity following infection (Groskreutz et al., 2006). Further experiments showed 
that TLR3 upregulation is due to the activation of the retinoic acid-inducible gene I (RIG-
I). RIG-I bound and was activated by RSV transcripts within 12 hours after infection. 
Knockdown of RIG-I expression prevented RSV-mediated activation of TLR3 and 
subsequent NF-κB activation (Liu et al., 2007).  TLR2 is essential for TNF-α production 
in macrophages infected with RSV.  Additionally, TLR2 signaling appears to be an 
important step in viral clearance, as TLR2 knockout mice contained higher viral titers in 
comparison to wild-type mice up to four days after infection (Murawski et al., 2009). 
RSV induces the activation of several cytokines and chemokines during infection. 
Cytokines are a family of secreted proteins that are induced in response to a variety of 
stimuli and function in regulating the immune response, inflammation, and 
hematopoiesis. Chemokines are a subset of cytokines that function to attract leukocytes to 
sites of viral or bacterial infection. RSV infection of airway epithelial cells results in the 
expression of proinflammatory cytokines and chemokines that include RANTES, MCP, 
eotaxin, IL-9, TNF-α, IL-6, IL-1, and CX3CL1 (Oshansky et al., 2009). Some or all of 
these signaling molecules may be responsible for enhanced pathogenesis of RSV 
infection. For example, mice infected with RSV that were treated with an anti-RANTES 
antibody exhibited significantly reduced signs of airway hyperreactivity (Tekkanat et al., 
2002). Similar experiments were performed with an anti-eotaxin antibody, these results 
again showed a decrease in disease in comparison to untreated mice (Matthews et al., 
2005). 
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Several studies have examined the impact of specific RSV proteins on immune 
signaling. Expression of RSV F alone stimulates TLR4 production. The RSV SH protein 
functions as a TNF-α antagonist protein (Fuentes et al., 2007). TNF-α is an important 
signaling molecule involved in NF-κB activation, cell proliferation, and induction of 
apoptosis (Gaur and Aggarwal, 2003). Cells infected with a viral construct lacking the 
SH gene produced a greater amount of TNF-α in response to infection. In addition, 
expression of SH alone by transfection prevented activation of NF-κB upon exogenous 
addition of TNF-α to transfected cells. Structural studies have shown that RSV G 
contains a domain that is homologous with a portion of the TNF receptor. It is possible 
that the secreted form of RSV G can bind to TNF-α and prevent the molecule from 
properly signaling through its receptor (Langedijk et al., 1998).  
Type I interferon is essential for mounting a complete innate response to viral 
infection. IFN is responsible for inducing a number of key antiviral proteins in both 
infected cells and uninfected neighboring cells (Boo and Yang, 2010). Interestingly, RSV 
infection appears to be largely resistant to IFN signaling (Atreya and Kulkarni, 1999). 
Early studies attempting to identify the mechanism by which RSV inhibits IFN induction 
showed that the nonstructural proteins, NS1 and NS2, are essential for this function. RSV 
gene deletion viruses that lack the NS1 and NS2 genes induce much higher levels of IFN 
in infected airway epithelial cells when compared to wild-type virus (Spann et al., 2004).  
Further experiments revealed that NS1 and NS2 target the IFN intermediate signaling 
molecule, STAT2, for degradation (Lo et al., 2005). NS1 is capable of acting like an E3 
ligase, causing the ubiquitination and subsequent degradation of STAT2 during infection, 
initiating binding of the E3 ubiquitin ligase to STAT2 (Elliott et al., 2007). 
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 CHAPTER II 
 
 
 
RESPIRATORY SYNCYTIAL VIRUS INDUCES HOST RNA STRESS 
GRANULES TO FACILITATE VIRAL REPLICATION 
 
 
 
Introduction 
 
I began these studies with the intention of determining a role for RSV inclusion 
bodies. Previously, these structures had been proposed to be either viral replication 
factories or simply nonfunctional aggregates of excess viral protein. We were first 
introduced to stress granules by Dr. James Goldenring at Vanderbilt University. Dr. 
Goldenring encouraged us to delineate the differences between viral inclusion bodies and 
host stress granules.  As I performed my initial studies to identify sites of viral RNA 
production using in situ hybridization, we began collaborating with Dr. Philip Santangelo 
at the Georgia Institute of Technology. Dr. Santangelo provided us with much more 
sensitive RNA probes that were easier to work with and made much of this work 
possible. Thus, our work expanded greatly and we began to study the relationship 
between inclusion bodies, viral RNA, and stress granules. 
This section begins by confirming the presence of stress granules in virally 
infected cells. These structures are separate and distinct from viral inclusion bodies, save 
for one shared component, HuR. I found that viral replication is greatly reduced in cells 
that cannot form stress granules. Finally I found that although viral RNA can be found in 
stress granules, the vast majority is found in inclusion bodies. 
 
 
 20	  
Materials and Methods 
 
Cells. HEp-2 cells (ATCC CCL-23) were maintained in OPTI-MEM I medium 
(Invitrogen) containing 5% (v/v) fetal calf serum, 1% (v/v) L-glutamine, 2.5 µg/mL 
amphotericin B, and 50 µg/mL gentamicin. MA104 cells (ATCC CRL 2738.1), which 
were used to prepare rotavirus, and RGD3 and U2OS cells (kindly provided by Paul 
Anderson, Brigham and Women’s Hospital) were maintained in DMEM containing 5% 
(v/v) fetal calf serum, 1% (v/v) sodium pyruvate, 1% (v/v) L-glutamine, 1% (v/v) non-
essential amino acids, 2.5 µg/mL amphotericin B, and 50 µg/mL gentamicin. 
 
Viruses. A suspension of RSV wild-type strain A2 prepared in HEp-2 cells (1 x 106 
pfu/mL) was used to infect HEp-2 cell monolayer cultures. Infectious virus was adsorbed 
to the cells for one hour in a 37 °C incubator in 5% CO2. Following adsorption, the 
inoculum was removed and fresh medium added.  Cells then were incubated at 37 °C in 
5% CO2 for the duration of the infection period. UV inactivated virus was prepared from 
the same virus stock by irradiation in a UV crosslinker for 15 minutes. Rhesus rotavirus 
(RRV) was a kind gift from Susana Lopez. 
 
Fixation and immunostaining. Cells were fixed with 3.7% (w/v) paraformaldehyde in 
phosphate buffered saline (PBS) for 10 minutes at room temperature. Cells were 
permeabilized with 0.2% (w/v) Triton X-100 and 3.7% paraformaldehyde in PBS for ten 
minutes at room temperature. Following fixation, cells were blocked in 5% (w/v) BSA in 
PBS for one hour followed by addition of primary antibody for one hour. Cells then were 
washed three times in PBS and species-specific IgG Alexa Fluor (Molecular Probes) was 
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added at a dilution of 1:1,000 in block solution for detection of primary antibodies. Cells 
were washed 3 times in PBS and fixed on glass slides using Prolong Antifade kit 
(Molecular Probes). Images were obtained on a Zeiss inverted LSM510 confocal 
microscope using a 40X Plan-Neofluar oil objective lens. Polyclonal anti-G3BP 
(ab37906) antibody was obtained from Abcam and used for immunostaining. The 
following antibodies were obtained from Santa Cruz for immunostaining: polyclonal anti-
TIA-1 (sc-1751), polyclonal anti-HuR (sc-20694), and polyclonal anti-eIF3η (sc-16377). 
Anti-RSV P protein (clone 3_5) and anti-RSV N protein (clone B130) monoclonal 
antibodies were a kind gift of Earling Norrby and Ewa Bjorling. An anti-RSV F protein 
humanized mouse monoclonal antibody (palivizumab; MedImmune) was obtained from 
the Vanderbilt Pharmacy. Imaging of the RNA with G3BP and RSV N protein was 
performed using a 63X, NA=1.4 Plan-Apochromat objective using a Zeiss LSM 510 
confocal microscope. For images where 3-dimensional z-stacks were obtained, we 
collapsed the series of fields into an extended view using Volocity imaging software.  
 
RT-PCR. HEp-2 cells were grown on 48-well plates and infected with RSV for indicated 
times.  RNA was extracted using the RNeasy mini kit (Qiagen).  RT-PCR was performed 
using the OneStep RT-PCR kit (Qiagen) and primer-probe combinations for RSV F, 
rotavirus VP3 or human GAPDH.  Normalized cycle threshold (ΔCt) was calculated for 
each time point using the following formula: ΔCt=RSV F Ct – GAPDH Ct. Change in 
normalized Ct over time (ΔΔCt) was calculated for each condition using the ΔCt of wild-
type cells two hours post infection as the initial point of reference for relative amount of 
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viral RNA: ΔΔCt= [ΔCt at X hour PI (+/-) shRNA] – [ΔCt 2 hour PI wild-type], where X 
equals each specific time point.   
 
shRNA reagents. A stable cell line exhibiting knockdown of HuR expression was 
generated using a set of three SMARTvector lentiviral shRNA particles (Dharmacon), 
along with cells treated with non-targeting shRNA particles.  HEp-2 cells were plated 
into 48-well plates at approximately 50% confluency and transduced with the lentiviral 
particles according to the manufacturer’s protocol. A panel of stable cell lines exhibiting 
knockdown of G3BP expression was generated using MISSION shRNA Lentiviral 
Transduction Particles (Sigma).  HEp-2 cells were plated onto 6-well plates and 
transduced with lentiviral particles according to the manufacturer’s protocol.  For 
selection of each target, cells containing integrated lentivirus sequences were selected 
using puromycin (5 µg/mL) diluted in medium. Medium containing puromycin was 
replaced every three days until resistant colonies were observed.  Puromycin-resistant 
colonies were isolated using cloning cylinders (Sigma) and tested for target protein 
expression.   
 
Western blots. HEp-2 cells were grown on 6-well plates and harvested for protein. Cell 
lysates were obtained using lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 1% Triton X-
100, pH 8.0) containing 0.5% (v/v) of protease inhibitor cocktail (Sigma) and 1.0% (v/v) 
of phosphatase inhibitors (Sigma).  Lysates were separated on 4-12% NuPAGE Bis-Tris 
gels (Invitrogen) and transferred to nitrocellulose membranes using an iBlot dry blotting 
system (Invitrogen).  Membranes were blocked for one hour using Odyssey blocking 
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buffer (Li-Cor) diluted 1:1 in PBS.  Primary antibodies were diluted in blocking buffer 
and incubated overnight at 4 °C.  Membranes then were washed four times in Tris 
buffered saline + 0.2% Tween (TBST) for five minutes each.  Li-Cor IRDye 680CW or 
IRDye 800CW secondary antibodies were diluted 1:5,000 in blocking buffer and added 
to each membrane for one hour.  Membranes were washed four times in TBST.  Bands 
were imaged and quantitated using the Odyssey Infrared Imaging System.  G3BP protein 
was detected using a monoclonal antibody from BD Biosciences (611127).  GAPDH was 
detected using a monoclonal antibody from Millipore (MAB374). HuR was detected 
using a monoclonal antibody from Santa Cruz Biotechnology (sc-5261). 	  
 
RNA probe and live cell delivery.  Single RNA sensitive probes (Santangelo et al., 
2009) designed to target the gene-start-intergenic region of the genomic RNA of hRSV 
were delivered at 30 nM via reversible-permeabilization with streptolysin O into separate 
sets of infected or mock-infected HEp-2 cells at 1, 6, 12, 18, and 24 hours PI.  Delivery 
took approximately 10 minutes, and 15 minutes after delivery the cells were fixed with 
3.7% (w/v) paraformaldehyde in PBS for 10 minutes at room temperature. The cells then 
could be immunostained for G3BP and the RSV N protein as discussed above.   
 
Quantification of imaging. To determine quantitative features of stress granule 
induction by RSV, HEp-2 cells were plated onto coverslips placed in wells of a 24-well 
plate. Cells were grown to approximately 75% confluency and were infected with RSV 
for 0, 6, 12, 16, 20 or 24 hours (MOI=1). Cells were fixed as above.  Cells were stained 
with anti-G3BP antibody (BD Transduction Laboratories) diluted 1:1,000 in block 
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solution, the anti-RSV F protein antibody palivizumab (MedImmune) diluted 1:10,000 in 
blocking solution and the nuclear stain TO-PRO-3 iodide (Invitrogen) diluted 1:1000 in 
block solution for one hour. Twenty high-powered fields (HPFs) were obtained for each 
time point.  Images were examined using Volocity imaging software (version 5.1, 
Improvision).  Each HPF was quantified for total number of cells by counting the number 
of nuclei. We also quantified the number of infected cells by staining for the presence of 
RSV F protein, the number of cells containing stress granules by staining for the presence 
G3BP protein, and number of infected cells that also contained stress granules per HPF. 
 To calculate stress granule size in wild-type or G3BP-deficient cells, cells were plated 
onto coverslips placed in wells of a 24-well plate.  Cells then were treated with 0.5 mM 
arsenite for 15 minutes.  Cells were fixed and stained for G3BP (1:500) and TIA-1 
(1:250). Images for 10 HPFs were obtained for each cell line.  We then used Volocity 
imaging software to determine the percentage of cells per HPF with stress granules and 
the size of each stress granule for those cells containing stress granules. To determine 
inclusion body number and volume, HEp-2 cells were placed on coverslips in 24-well 
plates. Cells were infected with RSV for 24 hours (MOI=1.0) and fixed. Cells were 
stained for inclusion bodies using anti-RSV P protein antibody and stress granules using 
anti-G3BP antibody. At least 10 cells containing or not containing stress granules were 
analyzed for inclusion bodies. Volocity imaging software was used to determine the 
number of and volume of individual inclusion bodies per cell. Volocity also was used to 
quantify the colocalization of the viral genomic RNA with inclusion bodies (marked by 
the RSV N protein) or with stress granules, in addition to colocalization of inclusion 
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bodies with stress granules.  Manders overlap coefficients were calculated using voxels 
generated from three-dimensional reconstructions. 
 
Results 
 
RSV infection induces stress granule formation. We first tested whether RSV infection 
of epithelial cells induced stress granules. HEp-2 cell monolayer cultures were inoculated 
with RSV wild-type strain A2 at an MOI of 1 pfu/cell and incubated in liquid medium for 
24 hours. We then fixed and immunostained the cells for the stress granule proteins 
G3BP, eIF3η, or TIA-1. Figure 2-1 (first column) shows that each of these markers 
frequently relocalized into dense cytoplasmic foci that are characteristic of stress 
granules. We noted that the host stress granules appeared similar in size, shape, and 
location to previously described viral inclusion bodies that form during RSV infection. 
To investigate whether the granules containing stress granule associated proteins were 
viral inclusion bodies, we co-stained infected cells with antibodies to stress granule 
markers and one of the viral proteins found in inclusion bodies (RSV P protein) (Figure 
2-1 middle column).  The results indicate that viral inclusion bodies are separated 
spatially from stress granules and represent distinct structures in the cytoplasm. We next 
performed a time course of infection to determine the kinetics of stress granule formation 
in RSV-infected cells. We inoculated cells with RSV (MOI=1 pfu/cell), then incubated 
for varying time points (0-24 hours). We fixed and immunostained cells for RSV F 
protein and the stress granule protein marker G3BP. After 12 hours, stress granules 
formed and the number of infected cells containing stress granules increased  
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Figure 2-1.  Stress granules are induced during RSV infection. HEp-2 cells were 
infected with RSV (MOI=1.0) for 24 hours, fixed and processed for 
immunofluorescence.  Anti-G3BP, anti-eIF3η, and anti-TIA-1 were used as stress granule 
markers and appear red in the merge panel.  Anti-RSV P was used as the viral inclusion 
body marker and appears green in the merge panel. The collapsed z-sections are shown 
for each image. 
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incrementally throughout the 24-hour period of observation (Figure 2-2). We did not 
observe stress granules in mock-infected cells over the time course. In addition, in the 
cultures in which RSV was added, we did not observe stress granules in cells that did not 
stain for RSV protein. These results demonstrated that RSV induces a potent stress 
granule response beginning at about 12 hours after inoculation and continuing throughout 
the viral life cycle.  
 
Stress granule formation is dependent on RSV replication. In order to verify that RSV 
replication is necessary for stress granule formation, we mock inoculated, inoculated with 
replication competent RSV (MOI=1.0 pfu/cell), or inoculated with an equivalent volume 
of UV-inactivated RSV for 48 hours, then fixed and immunostained for RSV F and 
G3BP. RSV infection once again induced robust stress granule formation (Figure 2-3 
bottom row) while we did not observe stress granules in mock inoculated or UV-
inactivated RSV inoculated samples (Figure 2-3 top and middle rows). These results 
confirmed that RSV replication, and not simply the presence of RSV protein is required 
for stress granule formation. We next compared RSV protein levels between cells with 
and without stress granules. HEp-2 cells were inoculated with RSV (MOI=1.0) for 24 
hours, then fixed and immunostained for RSV P and G3BP. We used RSV inclusion body 
size and number as a measure to compare the amount of viral protein present in cells. 
Interestingly, the results indicated that infected cells that have formed stress granules 
contain more inclusion bodies than cells that have not formed inclusion bodies (Figure 2-
4A). In addition, individual inclusion bodies were larger in cells that had formed stress 
granules (Figure 2-4B) and the total amount of protein contained in inclusion bodies was 
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Figure 2-2. Stress granule formation increases throughout infection. HEp-2 cells 
were infected with RSV (MOI=1.0) for indicated times.  The percentage of infected cells 
and cells containing stress granules per HPF was quantified as described in Materials and 
Methods. 	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Figure 2-3. RSV-induced stress granule formation is dependent on virus replication. 
HEp-2 cells mock infected (top row), inoculated with UV-inactivated RSV (middle row), 
or inoculated with replication competent RSV (MOI=1.0) (bottom row) for 48 hours were 
fixed and processed for immunofluorescence. Anti-G3BP was used as a marker for stress 
granules and appears red in the merge. Anti-RSV F was used as a marker for viral 
infection and appears green in the merge. The collapsed z-sections are shown for each 
image. 
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greater (Figure 2-4C). Although the quantification of size and number of inclusion bodies 
in infected cells in the cultures clearly showed larger and more inclusion bodies in cells 
with stress granules, we also did observe some individual cells without stress granules 
that contained high amounts of RSV protein (for example, two cells with high N 
expression in Figure 2-11, at 12 hours post-infection). These data suggested that stress 
granules enhance viral protein production and inclusion body formation, but are not 
absolutely required for these viral processes. 
 
Inhibition of host stress granule formation reduces RSV replication. To investigate 
whether stress granule formation is beneficial to the virus or host, we inoculated MEF 
lines derived from TIA-1 or TIAR deficient mice (kindly provided by Paul Anderson), 
however, RSV did not establish a productive infection in these cells. It is well-established 
that human RSV strains do not infect murine cells efficiently. Next, we created human 
cell lines deficient for stress granule formation by transducing HEp-2 cells with lentiviral 
shRNA transduction particles to induce stable knockdown of G3BP expression. When 
analyzed by western blot, G3BP was not detected in the knockdown cells (Figure 2-5A).  
However, when these cells were compared with wild-type cells by immunofluorescence, 
we could still observe a small amount of G3BP in fixed and permeabilized knockdown 
cells. The G3BP-deficient cells expressed normal amounts of other stress granule 
proteins, such as TIA-1 (Figure 2-5B). G3BP-deficient cells were treated with 0.5 mM 
arsenite for 15 minutes to determine if they were capable of forming stress granules.  
Stress granules were detected using anti-TIA-1 antibodies (Figure 2-6A). We compared  
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Figure 2-4. RSV protein levels are higher in cells with stress granules. HEp-2 cells 
were infected with RSV (MOI=1.0) for 24 hours. At least 10 infected cells containing or 
not containing stress granules were analyzed. (A) Total average number of inclusion 
bodies per cell was determined as described in the Materials and Methods for cells 
containing stress granules (+SGs) or not containing stress granules (No SGs). (B) The 
average volume (µm3) of individual inclusion bodies was determined for cells containing 
or not containing stress granules. (C) The volumes for all of individual inclusion bodies 
in single cells containing or not containing stress granules were totaled on a per cell basis 
to determine average total inclusion body volume per cell. 
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Figure 2-5.  shRNA knockdown of G3BP expression.  (A) Wild-type or representative 
G3BP-deficient HEp-2 cells were analyzed for G3BP expression via (A) western blot or 
(B) for G3BP (green in merge) and TIA-1 (red in merge) expression using indirect 
immunofluorescence. (C) Each cell type was treated with arsenite, fixed, and processed 
for immunofluorescence. Stress granule proteins were stained using anti-G3BP (green in 
merge) and TIA-1 (red in merge) antibodies and then examined (D) for percentage of 
cells containing stress granules per HPF and size of stress granules per cell using TIA-1 
as a marker for stress granules, as described in Materials and Methods. 
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the percentage of cells with stress granules per high-powered field. In G3BP-deficient 
cells, approximately 75% fewer cells formed stress granules per HPF. We also examined 
individual G3BP-knockdown cells that did form stress granules and noted that there was 
also a slight decrease in stress granule size when compared to those in wild-type HEp-2 
cells (Figure 2-6B). These results indicated that G3BP-deficient cells are impaired for 
stress granule formation.  
We next determined whether RSV replication was altered in the G3BP-deficient 
cell line. Wild-type or G3BP-deficient cells were infected with RSV (MOI=1 pfu/cell) for 
1, 2, or 4 days. Cell-associated and supernatant virus was collected separately and viral 
titer was determined using plaque assays. The G3BP-deficient cells consistently 
demonstrated a ten-fold reduction in viral titer when comparing supernatant- or cell-
associated virus with titers collected from wild-type cells (Figure 2-7A). In addition, RSV 
infection was associated with death of most wild-type HEp-2 cells after 2 days, while in 
contrast the G3BP-deficient cells consistently remained viable for 4 days after infection. 
We also determined the effects of G3BP overexpression on RSV replication using RGD3 
cells, a U2OS osteosarcoma cell line selected to express GFP-G3BP. We inoculated 
RGD3 or parental U2OS cells with RSV (MOI=1.0) and harvested cell-associated virus 
for plaque assays at time points spanning 0-4 days after inoculation. RSV replication 
remained largely unaltered in cells overexpressing G3BP (Figure 2-7B). Interestingly, 
although G3BP levels are higher in RGD3 cells, stress granule formation is largely 
unaltered (Kedersha et al., 2008). These data indicated that the presence of artificially 
elevated levels of G3BP do not enhance replication. 
We next sought to determine if reduction of G3BP expression and stress granule 
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Figure 2-6. Decreased levels of G3BP inhibit stress granule formation.	  (A) Wild-type 
or G3BP-deficient cells were treated with arsenite, fixed, and processed for 
immunofluorescence. Stress granule proteins were stained using anti-G3BP (green in 
merge) and TIA-1 (red in merge) antibodies and then examined (B) for percentage of 
cells containing stress granules per HPF and size of stress granules per cell using TIA-1 
as a marker for stress granules, as described in Materials and Methods.	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Figure 2-7.  RSV replication is inhibited in G3BP-deficient cells.  (A) Wild-type or 
representative G3BP-deficient cells were infected with RSV (MOI=1.0) for indicated 
times.  Cell-associated or supernatant virus was collected at each time point.  Viral titer 
for each sample was determined by plaque assay.  (B) Wild-type or G3BP-
overexpressing cells derived from U2OS cells (RGD3) were infected with RSV 
(MOI=1.0) for indicated times. Cell-associated virus was collected at each time point, 
and viral titer for each sample was determined by plaque assay. 
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formation affected the efficiency of replication of viral RNA. We inoculated wild-type or 
G3BP-deficient cells for 0, 2, 12, 24, or 48 hours and then harvested total RNA from cell 
lysates. We performed reverse transcriptase-PCR and normalized RNA levels to that of 
host GAPDH and compared with levels found at 2 hours post-infection in the wild-type 
HEp-2 cells. We observed a decrease in RSV RNA in the G3BP-deficient cell line at each 
time point tested after infection (Figure 2-8). Interestingly, when these cells were infected 
with rhesus rotavirus, a virus that does not induce stress granule formation (Montero et 
al., 2008), replication of rotavirus was unaffected. These data indicate that stress granule 
formation may play an important role in the RSV life cycle even at very early time points 
after infection. 
 
The stress granule marker HuR is recruited to RSV inclusion bodies. We examined 
other markers of stress granules and found a non-classical feature involving the mRNA-
binding stress granule protein HuR. In cells infected with RSV, HuR was recruited to 
stress granules during infection but the protein also was largely associated with structures 
that were not marked by other stress granule proteins.  When cells were inoculated with 
RSV (MOI=1) and co-stained for G3BP and viral proteins in RSV inclusion bodies, we 
noted that HuR was present both in host stress granules and in RSV inclusion bodies 
(Figure 2-9). Thus, HuR protein is a shared component between the two structures.  
 
HuR expression is not required for efficient RSV replication. Using RNA 
interference, we sought to determine the effect of decreased HuR expression on RSV 
replication. shRNA knockdown of HuR resulted in an approximately 70% reduction of 
 37	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-8. RSV replication is inhibited in G3BP-deficient cells. Wild-type or G3BP-
deficient cells were infected with RSV or rotavirus for indicated times.  Viral RNA was 
collected and assayed for fold change of RNA during infection using RT-PCR. 
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Figure 2-9.  HuR protein colocalizes with RSV inclusion bodies. HEp-2 cells were 
infected with RSV (MOI=1.0) for 24 hours, fixed and prepared for immunofluorescence.  
Anti-G3BP was used to mark stress granules and appears green in the merge.  Anti-RSV 
P was used to mark RSV inclusion bodies and appears red in the merge.  HuR appears 
blue in the merge.  White squares are used to mark areas in which HuR is contained in 
stress granules or inclusion bodies, respectively. The collapsed z-sections are shown for 
each image. 	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HuR expression when compared by western blot to wild-type cells or cells transduced 
with a non-targeting shRNA (Figure 2-10A). In contrast to G3BP knockdown, stress 
granule formation was not altered by HuR reduction when treated with sodium arsenite  
 (data not shown).  To test whether HuR plays a role in RSV infection, we inoculated 
wild-type HEp-2 or HuR-deficient cells with RSV (MOI=0.1) for 1, 2, 3, or 4 days. Viral 
supernatant and cell-associated virus was collected separately at each time point, and 
viral titer was determined by plaque assay.  As shown in Figure 2-10C, we did not 
observe a significant change in viral titer for supernatant or cell-associated virus during 
infection in HuR-deficient cells. In addition, we monitored for any changes in RSV RNA 
levels.  Wild-type or HuR-deficient cells were inoculated (MOI=0.1) for stated times and 
RNA was harvested.  We again performed quantitative RNA studies. As shown in Figure 
2-10B, we did not find a significant difference in RSV RNA levels when HuR expression 
was reduced. These data, combined with our viral titer results, indicate that wild-type 
level of HuR expression is not essential for viral replication even though a significant 
amount of HuR is recruited to inclusion bodies. 
 
RSV genomic RNA is partially localized to stress granules.  Previous reports using 
fluorescent molecular beacons specific for RSV genomic RNA suggested that RSV RNA 
could be found in RSV inclusion bodies during infection (Santangelo et al., 2006).  In 
addition, more recent studies have shown that RSV RNA transiently interacts with 
arsenite-induced stress granules as well (Santangelo et al., 2009).  Using a probe specific 
for RSV genomic RNA, we sought to determine whether RSV RNA could be found in 
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Figure 2-10.  HuR protein is not required for RSV replication.  (A) Cells transduced 
with non-targeting or HuR shRNA were compared with wild-type HEp-2 cells for 
expression levels of HuR.  Total HuR levels were quantified for each cell type and 
compared to wild-type levels. (B) Wild-type HEp-2, nontargeting shRNA cells, or HuR-
deficient cells were infected with RSV (MOI=0.1) for indicated times.  Viral RNA was 
collected and assayed for fold change of RNA during infection.  (C) Wild-type or HuR-
deficient cells were infected with RSV (MOI=0.1) for indicated times.  Cell-associated 
virus or supernatant virus was collected at each time point.  Viral titer for each sample 
was determined by plaque assay. 	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RSV-induced stress granules as well as RSV inclusion bodies.  HEp-2 cells were 
inoculated with RSV (MOI=1) for 1, 6, 12, and 24 hours.  After infection, cells were 
reversibly permeabilized with streptolysin O and incubated with fluorescently labeled 
RNA probes.  Cells then were fixed with paraformaldehyde and stained with a  
RSV N antibody to identify inclusion bodies and a monoclonal anti-G3BP antibody to 
identify stress granules (Figure 2-11). Using confocal microscopy, we then examined the 
localization of viral RNA at each time point.  We observed colocalization between RSV 
inclusion bodies and viral RNA at all time points, quantifying 1, 12, and 24 hours after 
infection as shown in Figure 2-11. Using Volocity imaging software, we determined the 
average Manders overlap coefficients for the inclusion bodies with viral RNA, inclusion 
bodies with stress granules, and viral RNA with stress granules utilizing three fields of 
approximately 35 cells (Table 2-1). The images in Figures 2-11 and 2-12 and the data for 
Table 2-1 were kindly provided by Dr. Philip Santangelo and Aaron Lifland from the 
Georgia Institute of Technology. For viral RNA and inclusion bodies, the Manders 
overlap coefficient was 0.87, 0.96, and 0.91 (87, 96, and 91% overlap) for 1, 12 and 24 
hours after infection, respectively.  For the inclusion bodies with stress granules, the 
average Manders overlap coefficient was 0.0, 0.016, and 0.034 (0 – no stress granules, 
1.6 and 3.4 % overlap), likely representing a transient interaction. For the viral RNA with 
stress granules, the average Manders overlap coefficient was 0.0, 0.022, and 0.045 (0 – 
no stress granules, 2.2, and 4.5% overlap), also likely representing a transient interaction. 
In addition, we show the overlapping intensity profiles of the viral RNA, inclusion 
bodies, and stress granules (as visualized in images in the first column of Figure 2-12) to 
demonstrate the amount of colocalization between each. Single plane confocal images 
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Figure 2-11.  Viral genomic RNA predominantly colocalizes with RSV inclusion 
bodies. HEp-2 cells were mock-infected or infected with RSV (MOI=1) for indicated 
times.  RSV RNA-specific probes were added as described in the Materials and Methods. 
Cells were fixed and processed for immunofluorescence. Anti-RSV N was used as an 
inclusion body marker and appears green in the merge panel.  Anti-G3BP was used as a 
stress granule marker and appears blue in the merge panel.  RSV RNA (vRNA) appears 
red in the merge panel (fourth column). The main images are XY, and the images above 
and below represent XZ and YZ cross-sections. The horizontal lines are scale bars, while 
the diagonal or vertical lines were used to calculate the intensity profiles. 
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Table 2-1. RSV RNA is predominantly associated with viral inclusion bodies. 
 
 
 	  
 % Co-localization at time post infection 
 1 hour 12 hours 24 hours 
Viral RNA + inclusion bodies 87 96 91 
Viral RNA + stress granules 0.0 2.2 4.5 
Inclusion bodies + stress granules 0.0 1.6 3.4 
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from the middle of cells that best reveal stress granules did not always also capture 
optimal representation of inclusion bodies and viral RNA in that cell (for ex 12 hr PI). 
Therefore, we also provided merge images for these structures at the surface of the same 
cells (Figure 2-12, second column). 
 
Discussion 
These experiments show that inoculation of human cells with RSV induces stress 
granules within 12 hours of inoculation, and the frequency of stress granules increases 
with time since inoculation. Although stress granule formation typically is associated 
with translation inhibition resulting in a potentially antiviral state, the findings here show 
that impairment of stress granule formation by G3BP-knockdown reduces RSV 
replication. In addition, the presence of stress granules was associated with more robust 
viral protein expression on a per-cell basis. Our data also suggest that even though RSV 
induces stress granules and these structures contain many RNA binding proteins, the site 
of viral RNA production is in viral inclusion bodies and not stress granules. 
Following attachment and entry, RSV begins its life cycle with gene transcription 
using an RNA-dependent viral RNA polymerase.  Following accumulation of viral 
mRNAs and proteins the viral polymerase switches from a predominant mode of 
transcription of mRNAs to replication of the viral genome. Interestingly, our results 
indicate that stress granule formation begins approximately when RSV initiates this 
switch.   
          G3BP was first described as an essential stress granule assembly protein through 
experiments that demonstrated that overexpression of G3BP results in spontaneous 
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Figure 2-12. Viral genomic RNA predominantly colocalizes with RSV inclusion 
bodies.  Intensity profiles at each time point from Figure 2-10 demonstrating the strong 
correlation between the N protein and viral genomic RNA (first column). Imaging of N 
(green), viral genomic RNA (red) and G3BP (blue) in mock, 1, 6, 12, and 24 hours post-
infection at an image plane near the cell surface (second column). 
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formation of stress granules (Tourriere et al., 2003). Cells in which G3BP expression was 
modestly reduced by 30% using transient siRNA transfection were treated with arsenite.  
In these experiments large stress granules without G3BP could be observed in some cells 
while other cells contained smaller and fewer stress granules (White et al., 2007).  TIA-1 
also has been proposed to be an essential stress granule assembly protein.  Previous 
reports demonstrated that TIA-1 knock-out mouse embryo fibroblasts treated with 
arsenite displayed a diminished capacity to form stress granules (Gilks et al., 2004).  It 
has been proposed that these two proteins mediate stress granule formation in similar 
ways, because both proteins bind mRNA and both exhibit auto-aggregation properties.  
Other stress granule proteins such as TIAR (Gilks et al., 2004) and HuR (our studies) 
have been knocked down but appear to have little effect on stress granule formation.  It 
should be noted that G3BP plays a role in other cellular functions besides stress granule 
formation.  G3BP has been well characterized as a binding partner for Ras GTPase 
activating protein (RasGAP), a factor important in cellular proliferation pathways (Parker 
et al., 1996).  In addition, G3BP is known to be a mRNA-binding protein with an 
endoribonuclease function (Gallouzi et al., 1998; Tourriere et al., 2001). Thus, 
knockdown of G3BP may have other unknown consequences on viral replication 
independent of stress granule formation.  
In addition to RSV, parainfluenza virus 5 and Sendai virus are two other 
paramyxoviruses that are known to induce stress granules (Carlos et al., 2009; Iseni et al., 
2002).  In each case, stress granules were shown to be present at relatively late time 
points after infection (18-24 hours).  This finding is in contrast to results with other 
viruses such as poliovirus and Semliki Forest virus that induce stress granules early after 
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infection but restrict stress granule assembly at later time points (McInerney et al., 2005; 
White et al., 2007).  Thus, it is possible that stress granule formation enhances 
paramyxovirus replication during a portion of the viral life cycle.  Further evidence of 
this enhancement comes from our results in G3BP-deficient cells.  In these cells, stress 
granule formation was impaired and consequently viral replication was reduced.  Other 
viruses such as West Nile virus and vaccinia virus recruit specific proteins involved in 
stress granule formation such as TIA-1 and G3BP respectively to viral replication 
factories (Emara and Brinton, 2007; Katsafanas and Moss, 2007).   Our results show that 
neither TIA-1 nor G3BP associated with RSV RNA and neither protein was recruited to 
RSV inclusion bodies, which are the likely sites of viral replication.  
HuR is a known mRNA binding protein thought to act as a translation enhancer.  
The protein typically binds AU-rich regions of the 3ʹ′ untranslated regions (UTR) of 
mRNAs and is a known component of stress granules (Kedersha et al., 2002).  In 
addition, HuR has been shown to interact with elements of multiple viruses.  HuR was 
shown to bind to the 3ʹ′ UTR of hepatitis C virus (HCV) (Spangberg et al., 2000). 
Knockdown of HuR resulted in reduction of HCV replicon RNA (Korf et al., 2005) 
indicating a potential role in HCV replication.  Recently HuR was shown to interact with 
the HIV reverse transcriptase protein (Rivas-Aravena et al., 2009).  When HuR was 
knocked down, HIV reverse transcription was impaired. Conversely, over-expression of 
HuR increased HIV reverse transcription.  In our studies, although we observed HuR 
localization in viral inclusion bodies, knockdown of HuR by up to 70% did not affect 
viral replication. It is thus likely that HuR is not essential for RSV replication, or it is 
possible that modest levels of this protein can maintain such a role.   
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Interactions between viral RNA and stress granule proteins have been described. 
Previous studies have shown that Sendai virus RNA contains TIAR-binding sites, 
suggesting viral RNA interaction with stress granule proteins (Iseni et al., 2002).  The 
West Nile virus 3ʹ′ terminal stem loop RNA binds TIA-1 and TIAR (Li et al., 2002).  In 
addition, we recently showed that RSV RNA interacts transiently with stress granules 
when infected cells were treated with arsenite (Santangelo et al., 2009).  In these studies, 
individual granules of RSV RNA were observed to move into juxtaposition with stress 
granules, dock, and then separate again.  We observed similar transient interactions 
between RSV RNA and stress granules here, however our data suggest that viral genomic 
RNA is much more abundant in viral inclusion bodies.   
Detailed understanding of the molecular mechanisms underlying stress granule 
effects during viral infection is lacking.  In fact, evidence exists for both pro-viral and 
anti-viral roles.  When TIA-1 knockout cells that exhibit impaired stress granule 
formation were infected with VSV or Sindbis virus, both viruses grew to higher titers, 
indicating that TIA-1 or possibly stress granules are restrictive to these viruses (Li et al., 
2002).  However infection of TIAR knockout cells with West Nile virus resulted in 
decreased viral titers, suggesting a pro-viral role for this protein.  It is important to note 
however, that the functional role of stress granules in any sort of stress condition is still 
not completely understood. Stress granules have been proposed to be sites of mRNA 
sorting during periods of translation inhibition generated by a variety of stresses 
(Kedersha and Anderson, 2002).  While multiple species of mRNA have been shown to 
be associated with stress granules, this association appears to be transient in nature 
(Kedersha et al., 2005; Kedersha et al., 1999; Mazroui et al., 2007). More recent studies 
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have suggested that mRNA cycles between the cytoplasm and stress granules, and that 
the vast majority of cellular mRNA remains cytoplasmic, suggesting that these structures 
are neither a holding nor modification site for mRNAs (Mollet et al., 2008).   
Our studies suggest a functional role for stress granules during RSV infection that 
enhances replication. Further experiments will need to be carried out to determine the 
exact mechanism of induction and the true role of these structures.  Identification of a 
specific function of stress granules during viral infection also could elucidate a general 
function for these structures in the normal cell life cycle.  
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CHAPTER III 
 
 
RSV REPLICATION IS NOT DEPENDENT ON PKR-STIMULATED STRESS 
GRANULE FORMATION 
 
Introduction 
Following the observations I made in Chapter I, I designed a number of 
experiments to determine the upstream signaling pathways that lead to RSV-induced 
stress granule formation. As mentioned in the introduction, there are four known kinases 
that phosphorylate eIF2α, resulting in stress granule formation. I reasoned that the most 
likely of these kinases activated by RSV was PKR, given that many viruses are known to 
regulate expression and activation of this kinase. I attempted several methods to inhibit 
PKR, but here I present the two most reliable methods we found to block PKR activation. 
 In this chapter, I first determine that eIF2α and PKR are both phosphorylated 
during RSV infection. I then present data to show that the PKR inhibitor, 2-aminopurine 
(2-AP), also restricts RSV replication. However, knockdown of PKR by shRNA does not 
affect RSV replication. I then demonstrate that the reduction in RSV replication mediated 
by 2-AP treatment is independent of PKR expression or activation. Finally, I show that 
activation of PKR is the primary mechanism by which RSV induces stress granules. 
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Materials and Methods 
 
Cells. HEp-2 cells (ATCC CCL-23) were maintained in OPTI-MEM I medium 
(Invitrogen) containing 5% (v/v) fetal calf serum (Sigma), 2 mM L-glutamine 
(Mediatech), 2.5 µg/mL amphotericin B (Mediatech), 10 µg/mL streptomycin 
(Mediatech), and 10 U/mL penicillin (Mediatech). L929 cells were grown in either 
suspension or monolayer cultures in Joklik’s modified Eagles minimal essential medium 
(SMEM, Lonza) supplemented to contain 5% (v/v) fetal bovine serum (FBS, Invitrogen), 
2 mM L-glutamine (Invitrogen), 100 U/mL of penicillin, 100 µg/mL of streptomycin 
(Invitrogen), and 250 µg/mL amphotericin B (Sigma).  
 
Viruses. A suspension of RSV wild-type strain A2 prepared in HEp-2 cells (1 x 106 
pfu/mL) was used to infect HEp-2 cell monolayer cultures. Infectious virus was adsorbed 
to the cells for one hour in a 37 °C incubator in 5% CO2. Following adsorption, the 
inoculum was removed and fresh medium added.  Cells then were incubated at 37 °C in 
5% CO2 for the duration of the infection period. Reovirus strain T1L was a kind gift from 
the laboratory of Dr. Terence Dermody. 
 
Viral titration. For RSV plaque assays, cell-associated virus was harvested at indicated 
times by scraping infected HEp-2 cell culture monolayers into 1.0 mL of medium. Virus 
then was released from harvested cells as described previously (Utley et al., 2008). Viral 
titers were determined using plaque assays as described previously (Murphy et al., 1990). 
For reovirus, titers were determined by plaque assay using L929 cells. Reovirus-infected 
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HEp-2 cells were scraped into the medium, frozen at -80°C and thawed at room 
temperature twice prior to determination of viral titer in the suspension by plaque assay 
(Virgin et al., 1988).  Reovirus yields were calculated according to the following formula: 
log10 yieldt = log10 (PFU/mL)t – log10 (PFU/mL)t0 where t is the time postinfection, t0 is 
the time at inoculation after absorption. 
 
2-Aminopurine (2-AP) treatment. We generated a 150 mM stock solution of 2-AP 
(Sigma A3509) diluted in phosphate buffered saline (PBS) and glacial acetic acid (Fisher 
A-38-500).  Glacial acetic acid was diluted at a ratio of 1:200 in PBS. For each use, the 
solution was heated to 60 °C for re-suspension. HEp-2 cells were pretreated with 10 mM 
2-AP diluted in medium or mock-treated with vehicle (glacial acetic acid in PBS). Cells 
then were infected with RSV in the presence of 10 mM 2-AP or vehicle for one hour. 
Following infection, inoculum was removed and replaced with fresh medium containing 
10 mM 2-AP or vehicle and incubated for the duration of infection. 
 
Fixation and immunostaining. Cells were fixed with 3.7% (w/v) formaldehyde in PBS 
for 10 minutes at room temperature. Cells were permeabilized with 0.2% (w/v) Triton X-
100 and 3.7% paraformaldehyde in PBS for 10 minutes at room temperature. Following 
fixation, cells were blocked in 5% (w/v) BSA in PBS for one hour followed by addition 
of primary antibody for one hour. Cells then were washed three times in PBS and 
species-specific IgG Alexa Fluor (Molecular Probes) was added at a dilution of 1:1,000 
in block solution for detection of primary antibodies. Cells were washed 3 times in PBS 
and fixed on glass slides using Prolong Antifade kit (Molecular Probes). Images were 
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obtained on a Zeiss inverted LSM510 confocal microscope using a 40X Plan-Neofluar oil 
objective lens. A polyclonal anti-G3BP (ab37906) antibody was obtained from Abcam 
and used for immunostaining.  Monoclonal anti-phosphorylated eIF2α (1090-1) and anti-
PKR (1511-1) antibodies were from Epitomics. An anti-RSV F protein humanized mouse 
monoclonal antibody (palivizumab; MedImmune) was used to identify RSV F protein. 
Anti-RSV P protein (clone 3_5) monoclonal antibody was a kind gift of Earling Norrby 
and Ewa Bjorling.  
 
shRNA reagents. Lentiviral shRNA particles were obtained from Dharmacon for human 
GAPDH (S-001000-01), a non-targeting control (S-005000-01), and a set of three PKR 
SMARTvector shRNA constructs (SK-003527-00-10). HEp-2 cells were plated in 96-
well plates and transduced with individual lentiviral constructs according to the 
manufacturer’s protocol. For selection of each target, cells containing integrated 
lentivirus sequences were selected using puromycin (5 µg/mL) diluted in medium. 
Medium containing puromycin was replaced every three days until resistant colonies 
were observed. 
 
Western blots. HEp-2 cells were grown on 6-well plates and harvested for protein. Cell 
lysates were obtained using lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 1% Triton X-
100, pH 8.0) containing 0.5% (v/v) of protease inhibitor cocktail (Sigma) and 1.0% (v/v) 
of phosphatase inhibitors (Sigma).  Lysates were separated on 4-12% NuPAGE Bis-Tris 
gels (Invitrogen) and transferred to nitrocellulose membranes using an iBlot dry blotting 
system (Invitrogen).  Membranes were blocked for one hour using Odyssey blocking 
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buffer (Li-Cor) diluted 1:1 in PBS.  Primary antibodies were diluted in blocking buffer 
and incubated overnight at 4 °C.  Membranes then were washed four times in Tris 
buffered saline + 0.2% Tween (TBST) for five minutes each.  Li-Cor IRDye 680CW or 
IRDye 800CW secondary antibodies were diluted 1:5,000 in blocking buffer and added 
to each membrane for one hour.  Membranes were washed four times in TBST.  Bands 
were imaged and quantitated using the Odyssey Infrared Imaging System.  Total PKR or 
phosphorylated PKR were detected using monoclonal antibodies from Epitomics (1511-1 
and 2283-1, respectively). GAPDH was detected using a monoclonal antibody from 
Millipore (MAB374).  
 
Results 
 
RSV induces the phosphorylation of eIF2α and PKR. We have shown previously that 
RSV infection of cells potently induces stress granule formation (Chapter II), (Lindquist 
et al., 2010). We sought here to determine the mechanism by which RSV initiates this 
process. Typcially, stress granules form following induction of one of many types of 
stress-related pathways that result in a common downstream event, phosphorylation of 
the translation initiation factor, eIF2α (Kedersha and Anderson, 2007). Therefore, we 
examined cells inoculated with RSV (MOI=1.0 pfu/cell) for the presence of 
phosphorylated eIF2α using indirect immunofluorescence. We observed a striking 
increase in eIF2α phosphorylation beginning 12 hours post-inoculation that was 
concomitant with the appearance of stress granules and continued throughout infection 
(Figure 3-1).
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Figure 3-1. eIF2α is phosphorylated during RSV infection. HEp-2 cells were infected 
with RSV (MOI=1.0 pfu/cell) for the indicated times, fixed, and processed for 
immunofluorescence. Anti-RSV P monoclonal antibody was used to localize viral protein 
and appears green in the merge panel. Anti-TIA-1 antibody was used to detect stress 
granule formation and appears red in the merge panel. Phosphorylated eIF2α (peIF2α) 
appears blue in the merge panel.	  
 56	  
We next sought to determine the mechanism by which RSV mediates the phosphorylation 
of eIF2α. There are four well-defined kinases capable of eIF2α phosphorylation: protein 
kinase RNA (PKR), a kinase activated by double-stranded RNA; PKR-like ER-localized 
eIF2α kinase (PERK); general control nonrepressed 2 (GCN2); and heme-regulated 
inhibitor kinase (HRI) (Proud). In cells inoculated with RSV (MOI=1.0 pfu/cell) for 24 
hours, we observed phosphorylated PKR and higher expression of total PKR in 
comparison to mock-inoculated cells (Figure 3-2), consistent with previous reports. 
 
The chemical inhibitor 2-AP prevents PKR signaling and reduces RSV infection. To 
confirm that PKR activation is dispensable for RSV replication, we sought another 
method to inhibit activation of the kinase. The nucleotide analog 2-AP prevents PKR 
activation (Hu and Conway, 1993). We first tested whether 2-AP treatment alters RSV-
mediated PKR activation. HEp-2 epithelial cells were pretreated with 10 mM 2-AP or 
vehicle for two hours. We then inoculated cells with RSV (MOI=1.0 pfu/cell) in the 
presence of 2-AP or vehicle control for one hour. The inoculum was removed and 
replaced with medium containing 2-AP or vehicle, and the infection was allowed to 
proceed for 24 hours. Cell lysates were harvested for immunoblotting to assess the level 
of total or phosphorylated PKR. The phosphorylation of PKR in RSV-infected cells 
treated with 2-AP was greatly reduced in comparison to vehicle-treated cells (Figure 3-3). 
In addition, we did not observe an increase in total PKR levels in the presence of 2-AP 
that occurs during RSV infection following virus inoculation. As a control, we compared 
2-AP-treated and vehicle-treated cells in the absence of infection and found no changes in 
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Figure 3-2. RSV infection results in PKR activation. HEp-2 cells were mock-
inoculated or inoculated with RSV (MOI=1.0 pfu/cell) for 24 hours. Cell lysates were 
analyzed by immunoblots for GAPDH, RSV P, phosphorylated PKR, or total PKR. 
Relative protein densities comparing RSV-infected cells to mock-infected cells were 
quantified using Li-Cor Odyssey imaging software.
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Figure 3-3. Treatment with 2-AP prevents PKR activation during RSV infection. 
HEp-2 cells were pretreated with 10 mM 2-AP or vehicle. Cells then were mock-
inoculated or inoculated with RSV (MOI=1.0 pfu/cell) for 24 hours in the presence of 2-
AP or vehicle. Cell lysates were analyzed by immunoblots for GAPDH, RSV P, 
phosphorylated PKR, or total PKR. Relative protein densities were quantified using Li-
Cor Odyssey imaging software. The relative amount of RSV P protein expression was 
quantified for cells infected with RSV and treated with either vehicle or 2-AP. Protein 
levels were standardized to RSV-infected and vehicle-treated cells. The relative 
expression of PKR and phosphorylated PKR were quantified for each condition and 
compared to that of mock-infected cells treated with vehicle. 
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the levels of PKR or phosphorylated PKR. These results indicate that 2-AP inhibits PKR 
activation during RSV infection. We next assessed the effect of 2-AP treatment on viral 
protein expression using an immunobloting assay for RSV P protein as a surrogate 
marker. Relative amounts of total PKR, phosphorylated PKR, RSV P, and GAPDH were 
quantified using Odyssey imaging analysis software. Interestingly, we observed a 70% 
decrease in the amount of RSV P protein in 2-AP-treated cells in comparison to vehicle-
treated cells. This result suggests that treatment with 2-AP inhibits viral protein synthesis.  
To directly determine the effect of 2-AP treatment on RSV infection, we used 
indirect immunofluorescence to detect viral proteins in infected cells. Cells were 
pretreated with 2-AP or vehicle and inoculated with RSV (MOI=1.0 pfu/cell). After 24 
hours, cells were fixed and stained for the RSV F protein as a marker for infection 
(Figure 3-4A). RSV-infected cells per high-powered field (HPF) were quantified for each 
treatment. We observed an approximately 80% decrease in the percent of cells that 
stained positively for RSV F protein following 2-AP treatment (Figure 3- 4B). Thus, 2-
AP treatment diminishes RSV infectivity. 
To determine the effects of 2-AP treatment on the capacity of RSV to complete an 
infectious cycle, cells were pretreated with vehicle or 2-AP and inoculated with RSV 
(MOI=0.1 pfu/cell). After a one-hour adsorption, the inoculum was replaced with 
medium containing vehicle or 2-AP. Titers of cell-associated virus were determined at 
24-hour intervals for 0-4 days. The results show that 2-AP treatment mediated an 
approximately 1000-fold decrease in viral titer throughout the timecourse of infection 
(Figure 3-5A). To determine if 2-AP treatment affects viral entry, cells were pretreated 
with 2-AP and then inoculated with RSV (MOI=0.1 pfu/cell). The inoculum then was 
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Figure 3-4. Treatment with 2-AP reduces RSV infectivity. (A) HEp-2 cells were 
pretreated with 2-AP or vehicle, inoculated with RSV (MOI=1.0 pfu/cell) for 24 hours in 
the presence of 2-AP or vehicle, and processed for immunofluorescence. Anti-RSV F 
antibody was used to detect virus-infected cells. Differential interference contrast (DIC) 
was used to define the periphery of each cell. (B) The percentage of cells per HPF that 
stained positively for RSV F protein in images from (A) was determined. Error bars 
indicate SEM. 
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Figure 3-5. Treatment with 2-AP inhibits RSV replication. (A) HEp-2 cells were (i) 
pretreated with vehicle, inoculated with RSV (MOI=0.1 pfu/cell), and incubated in 
medium containing vehicle; (ii) pretreated with 2-AP, inoculated, and incubated in 
medium containing vehicle; or (iii) pretreated with 2-AP, inoculated, and incubated in 
medium containing 2-AP. (B) HEp-2 cells were incubated with vehicle or 2-AP and 
inoculated with reovirus (MOI=5.0 pfu/cell), in the presence of 2-AP or vehicle. Viral 
titers were determined at the intervals shown by plaque assay for (A) and (B). Error bars 
indicate standard deviations. 
 62	  
 
replaced with medium containing vehicle control only and incubated for 0-4 days. In 
contrast to cells incubated with 2-AP throughout infection, cells that had only been 
pretreated with 2-AP exhibited no change in viral titer when compared to vehicle-treated 
cells. These results suggest that 2-AP does not affect viral entry but rather a later step in 
the viral life cycle. To determine whether the effects of 2-AP treatment on RSV were 
virus-specific, we performed a similar experiment using reovirus. Reovirus replication is 
unaffected by PKR knockdown (Zhang and Samuel, 2007). In addition, the reovirus σ3 
protein inhibits PKR activation by competitively binding dsRNA targets (Sherry, 2009). 
In contrast to our results with RSV, 2-AP treatment only affected reovirus replication 
during the first 24 hours after infection. After 24 hours, we did not observe a significant 
difference in viral titers between 2-AP treated or vehicle-treated cells, indicating that 2-
AP treatment is much less inhibitory for reovirus replication in comparison to the effect 
on RSV (Figure 3-5B).  
 
Knockdown of PKR expression does not affect RSV replication.  We investigated 
what effects inhibition of PKR signaling might have on RSV replication. HEp-2 cells 
were transduced with shRNA lentiviral constructs specific for PKR or a non-targeting 
shRNA control. We selected for cells stably expressing the shRNA constructs and we 
compared PKR levels by immunoblotting in wild-type cells that were not transduced or 
cells transduced with PKR-targeting or non-targeting shRNA. Cells expressing the PKR 
shRNA construct exhibited an approximate 90% decrease in total PKR protein levels 
(Figure 3-6A) in comparison to wild-type cells or those expressing a non-targeting 
shRNA. Wild-type, non-targeting, or PKR-knockdown cells were inoculated with RSV 
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(MOI=1.0 pfu/cell) and incubated for 24 hours.  Immunoblot analysis of cell lysates did 
not demonstrate an increase in PKR phosphorylation in the RSV-inoculated PKR-
knockdown cells in comparison to wild-type or non-targeting shRNA cells. We next 
quantified the viral titers over a time course for each cell type. Cells were inoculated with 
RSV (MOI=0.1 pfu/cell) and incubated for 0-4 days. Cell-associated virus was harvested 
for each time point, and titers were determined by plaque assay. Viral titers in the PKR-
knockdown cells did not differ significantly from those in either wild-type cells or non-
targeting shRNA-expressing cells (Figure 3-6B). These results indicate that inhibition of 
PKR activation does not affect RSV replication. 
 
2-AP inhibits RSV replication in the absence of PKR. We next tested whether the 
effect on viral replication observed following 2-AP treatment requires PKR. We 
quantified the effect on viral titers in RSV-inoculated wild-type, non-targeting shRNA, or 
PKR-knockdown cells treated with 2-AP or vehicle. Cells were inoculated with RSV 
(MOI=0.1 pfu/cell) and incubated for 0-4 days. Cells were collected for each time point, 
and titers of cell-associated virus were determined by plaque assay. Treatment of cells 
with 2-AP once again mediated a 1000-fold reduction in viral titers throughout the time 
course (Figure 3-7A). Remarkably, 2-AP inhibited RSV replication in each cell type 
regardless if whether PKR was expressed or induced.  
We next treated wild-type, non-targeting shRNA, or PKR-knockdown cells with 
2-AP or vehicle and inoculated the cells with RSV (MOI=1.0 pfu/cell). Following 
incubation for 24 hours, we harvested the cell lysates and used immunoblots to detect 
total PKR, phosphorylated PKR, or RSV P. The results show that 2-AP inhibited RSV P 
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Figure 3-6. PKR knockdown does not affect RSV replication. (A) Wild-type HEp-2 
cells or HEp-2 cells transduced with nontargeting shRNA (NonT) or PKR-specific 
shRNA were mock-inoculated or inoculated with RSV (MOI=1.0 pfu/cell) for 24 hours.  
Cell lysates were analyzed by immunoblotting for total PKR, phosphorylated PKR, or 
GAPDH. (B) Each cell type from (A) was inoculated with RSV (MOI=0.1 pfu/cell) for 
the indicated times. Titers of cell-associated virus were determined for each time point by 
plaque assay. Error bars indicate standard deviations.	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Figure 3-7. Treatment with 2-AP inhibits RSV replication independent of PKR. ((A) 
Wild-type HEp-2 cells or HEp-2 cells transduced with nontargeting shRNA (NonT) or 
PKR-specific shRNA were pretreated with 10 mM 2-AP or vehicle. Cells were 
inoculated with RSV (MOI=0.1 pfu/cell) in the presence of 2-AP or vehicle for the 
indicated intervals. Titers of cell-associated virus were determined for each time point by 
plaque assay. (B) Each cell type from (A) was pretreated with 10 mM 2-AP or vehicle 
and inoculated with RSV (MOI=1.0 pfu/cell) for 24 hours in the presence of 2-AP or 
vehicle. Cell lysates were subjected to immunoblotting for RSV P protein and GAPDH. 
The relative amount of RSV P protein was quantified for each cell type and compared to 
that in wild-type cells treated with vehicle. Error bars indicate standard deviations.	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production in each cell type, independent of PKR levels (Figure 3-7B). Taken together, 
these data indicate that inhibition of PKR activation does not affect RSV replication. 
Furthermore, the decrease in RSV replication by 2-AP appears to be mediated via a PKR-
independent mechanism. 
 
PKR knockdown cells infected with RSV form fewer stress granules. We next 
determined whether PKR is the kinase responsible for stress granule formation during 
RSV infection. We infected wild-type, shRNA non-targeting, or PKR-knockdown cells 
with RSV for 48 hours (MOI=5.0 pfu/cell). We then examined cells for the presence of 
stress granules using indirect immunofluorescence (Figure 3-8). In wild-type and shRNA 
non-targeting cells, we observed robust stress granule formation in infected cells. 
However, in PKR-knockdown cells, stress granule formation was substantially 
diminished. These results confirm that PKR is required for stress granule formation 
following RSV infection.. As expected, the PKR knockdown cells displayed decreased 
staining for PKR, although this population was heterologous in PKR expression. We 
observed many fewer cells with stress granules in the PKR knockdown line, indicating 
that PKR is probably the primary mechanism by which RSV induces stress granules. 
Figure 3-9 shows that among those cells that formed stress granules in the PKR 
knockdown line, cells expressing the highest levels of PKR were more likely to form 
stress granules, although not all of the PKR-high cells formed stress granules. 
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Figure 3-8. PKR knockdown reduces RSV-mediated stress granule formation. Wild-
type cells or HEp-2 cells transduced with nontargeting shRNA (NonT) or PKR-specific 
shRNA were inoculated with RSV (MOI=5.0 pfu/cell) for 48 hours, fixed, and 
processesed for immunofluoresence. Anti-G3BP monoclonal antibody was used to detect 
stress granules and appears green in the merge panel. Anti-RSV F antibody was used to 
localize viral protein and appears red in the merge panel. PKR appears blue in the merge 
panel.	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Figure 3-9. PKR-high cells are more likely to form stress granules during RSV 
infection. PKR knockdown cells were infected with RSV (MOI=5.0) for 48 hours and 
processed for immunofluorescence. G3BP was used to detect stress granules and appears 
green in the merge. RSV F was used to detect RSV infection and appears red in the 
merge. PKR appears blues in the merge panel. 
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Discussion 
 
Since RSV induces the expression and activation of PKR, we hypothesized that 
activation of this dsRNA detector would mediate an antiviral effect during RSV 
infection. Surprisingly, we found that knockdown of PKR protein levels does not affect 
RSV replication. However, treatment with the kinase inhibitor 2-AP (which inhibits 
PKR) effectively blocks RSV replication regardless of PKR expression. This PKR-
independent effect on RSV replication suggests that induction of other PKR-like kinases 
which are 2-AP sensitive, enhance RSV replication. The identity of such kinases is not 
known. 
Our results are unexpected for two main reasons. First, PKR initiates a cascade of 
events resulting in phosphorylation of eIF2α and stress granule formation. These events 
are associated with stalled translation initiation complexes, which might be expected to 
diminish the capacity of host cells to support viral replication. Second, induction of PKR 
is often associated with an antiviral state. For example, both vesicular stomatitis virus and 
influenza virus replicate to higher titers in PKR-/- mice in comparison to wild-type mice 
(Balachandran et al., 2000). Similarly, PKR-/- mice succumb to infection at a higher 
frequency when infected with Bunyamwera virus in comparison to wild-type mice 
(Streitenfeld et al., 2003). However, there are cases, in which PKR has a minimal effect 
on viral replication. Severe acute respiratory syndrome coronavirus replication is 
unaffected in cells treated with phosphorodiamidate morpholino oligomers specific for 
PKR mRNA (Krahling et al., 2009).  Similarly, treatment of cells with PKR siRNAs has 
little effect on adenovirus or reovirus replication (Zhang and Samuel, 2007) or rotavirus 
protein synthesis (Rojas et al., 2010).  Rift Valley fever virus replication is not altered in 
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PKR -/- mouse embryo fibroblast cells (Habjan et al., 2009). However, PKR effects are 
not always antagonistic to viral infection. Knockdown of PKR by shRNA results in 
significantly decreased HCV RNA levels in cells treated with exogenous interferon and 
infected with HCV (Garaigorta and Chisari, 2009). Interestingly, levels of other proteins 
involved in the antiviral response are increased, suggesting that HCV induces PKR 
activation to inhibit host translation and prevent the expression of interferon-stimulated 
genes. We predicted a similar function for PKR during RSV infection since previous 
reports have demonstrated that 2-AP treatment leads to a dose-dependent increase in IFN-
α production in RSV-infected cells (Hornung et al., 2004). 
Although RSV is a single-stranded RNA virus, it produces multiple dsRNA 
intermediates during replication that are capable of activating PKR. PKR activation is 
likely required for eIF2α phosphorylation and subsequent stress granule formation during 
RSV infection (Lindquist et al., 2010) and (Hanley et al., 2010). Other studies have 
reported that RSV induces robust PKR activation during infection, but eIF2α 
phosphorylation is limited (Groskreutz et al., 2010). Phosphorylation of eIF2α may have 
been dampened by increased activity of protein phosphatase 2A (PP2A) during infection. 
In contrast, we observed extensive eIF2α phosphorylation during RSV infection, 
predominantly in cells that had been infected with RSV and in which stress granules had 
formed (Figure 1). Since phosphorylation of eIF2α frequently precedes stress granule 
formation (Kedersha and Anderson, 2007), our results are not surprising given the 
extensive stress granule formation induced by RSV (Lindquist et al., 2010).  It is possible 
that PP2A activity is not sufficient to reverse eIF2α phosphorylation in RSV-infected 
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cells that form stress granules. Further experiments are required to assess PP2A activity 
in such cells. 
Experiments using PKR-knockout mice show that RSV RNA levels increase 
during infection, suggesting a classic role for PKR as an antiviral molecule.  In PKR-
knockout mice, RSV infection induces lower levels of several cytokines, including TNF-
α, IFN-β, and RANTES, among others, in comparison to wild-type mice. These results, 
when combined with histological analysis of mouse lung tissue, suggest that functional 
PKR leads to enhanced pathogenesis in RSV-infected animals (Minor et al., 2010). 
Our previous data show that RSV replication is reduced in cells in which stress 
granule formation is inhibited by knockdown of the stress granule-related Ras-GAP SH3 
domain-binding protein (G3BP) (Lindquist et al., 2010). In the current study, we found 
that RSV replication is unaffected in PKR-knockdown cells that similarly are deficient 
for stress granule formation. One possible explanation for this discrepancy is that 
knockdown of G3BP has effects in addition to inhibiting stress granule formation. Thus, 
viral replication might be inhibited by an alternative effect of the G3BP knockdown. 
Another possibility is that in PKR-knockdown cells, PKR signaling does not occur, 
preventing the activation of intrinsic antiviral responses to the virus. Thus, the potential 
pro-viral function for which stress granules may normally be required would not be 
necessary, allowing the virus to replicate efficiently. 
 The drug 2-AP has been cited as a specific inhibitor of PKR activation (Hu and 
Conway, 1993) (Loving et al., 2006) and (Silva et al., 2004) and used in a number of 
studies examining the role of PKR during viral infection. However, 2-AP also may 
inhibit activation of tumor suppressor p53 during genotoxic stress (Huang et al., 2003), 
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interfere with cell cycle progression (Andreassen and Margolis, 1994), and inhibit 
mitogen-activated protein kinase activation (Thorburn et al., 1994). Although PKR 
activation has been implicated in each of these processes (Garcia et al., 2006), it is 
possible that 2-AP inhibits multiple kinases. Our results demonstrate that while 2-AP is 
efficient at blocking PKR activation during RSV infection, its inhibitory effect on RSV 
replication is PKR-independent. Therefore, the reliability of 2-AP as a PKR-specific 
inhibitor is suspect, given that the drug mediates non-PKR-dependent effects. Defining 
the other targets of 2-AP might lend insight into the complex perturbations that occur in 
host gene function during RSV infection.  
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CHAPTER IV 
 
SUMMARY AND FUTURE DIRECTIONS 
 
Thesis Summary 
The research I presented in this thesis examined the role of stress granules in RSV 
infection. I showed that RSV induces a robust stress response during infection and that 
inhibition of this response severely limits viral replication. I also showed that activation 
of PKR is the likely the mechanism by which RSV is able to induce stress granule 
formation. 
In Chapter II, we showed that RSV infection results in stress granule formation.  
Using indirect immunofluorescence, we observed stress granules forming in RSV 
infected cells starting approximately 12 hours after inoculation. As infection progressed, 
we observed a higher percentage of infected cells forming stress granules. We also noted 
that these structures were separate and distinct from RSV inclusion bodies. An interesting 
correlation with this is that transcription of RSV genes generally ends approximately 12 
hours after infection and a switch to viral replication occurs. It is possible that this switch 
is a factor in inducing the formation of stress granules; perhaps through the increased 
production of dsRNA intermediates. UV-inactivated virus does not induce stress 
granules, suggesting a requirement for active viral replication to induce these structures. 
We then showed that infected cells that have formed stress granules contain greater 
amounts of viral protein in comparison to cells that have not formed stress granules. This 
was our first evidence that stress granules may actually play a pro-viral role in infection. 
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Our next series of experiments sought to determine the effects of stress granule 
inhibition on viral replication. To accomplish this, we first had to generate a cell line with 
diminished capability of to form stress granules At the time, two proteins had been 
identified that were necessary for stress granule formation, TIA-1 and G3BP. We 
attempted to infect TIA-1 -/- MEFs, but RSV was not capable of replicating in these 
cells. We then generated a G3BP knockdown HEp-2 cell line. These cells displayed 
decreased capacity to form stress granules when treated with an exogenous stressor such 
as arsenite.  When we infected these cells with RSV, we observed a significant decrease 
in viral titers throughout the time course in comparison to wild-type cells. Additionally, 
when we measured RSV RNA levels by RT-PCR, we observed a decrease in RSV RNA 
amounts in G3BP knockdown cells. These results also suggest a pro-viral role for stress 
granules in RSV replication. 
When we determined that RSV inclusion bodies were separate from stress 
granules, we stained cells with a panel of stress granule specific markers. With the 
exception of HuR, none of these markers colocalized with viral inclusion bodies. We 
considered HuR colocalization with inclusion bodies an interesting phenomenon given 
the role of HuR in mRNA stabilization and our hypothesis that inclusion bodies 
contained viral RNA. To determine the relationship between inclusion bodies and HuR, 
we generated HuR knockdown cells. Stress granule and inclusion body formation were 
unaffected by this knockdown. In addition, we observed no significant difference in viral 
titers between HuR knockdown cells and control cells. Similarly, we observed no change 
in RSV RNA levels when detected by RT-PCR between control and HuR knockdown 
cells. Although these data indicate that HuR probably does not play an essential role in 
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inclusion body formation or viral replication, our knockdown levels may not have been 
sufficient to affect these aspects of infection.  
Inclusion bodies have been theorized to be viral replication factories while 
numerous studies have shown that host RNAs are recruited to stress granules. Therefore, 
we attempted to determine a potential role for stress granules and inclusion bodies in viral 
RNA localization. To accomplish this, we introduced RSV genome-specific RNA probes 
into infected cells at multiple time-points. We then fixed and stained these cells for stress 
granules and inclusion bodies. Our results showed that although we could detect a small 
amount of RSV genomic RNA in stress granules, the majority of RNA was found in viral 
inclusion bodies. These findings suggest that RSV RNA only transiently associates with 
stress granules, which is in concordance with other RNA species that have been studied 
to date. This is also the strongest evidence to date that inclusion bodies serve as specific 
sites of RSV replication. 
In Chapter II we established the characteristics of stress granule formation in RSV 
infection as well as a potential role in replication. In Chapter III we sought to determine 
the mechanisms by which RSV induces this process. We first confirmed that the 
translation initiation factor, eIF2α, was phosphorylated during RSV infection. This 
process is the most well-characterized method of stress granule formation. Through 
indirect immunofluorescence, we observed phosphorylated eIF2α in RSV-infected cells 
that had formed stress granules. We next attempted to determine the likely mechanism by 
which eIF2α is phosphorylated in RSV infected cells. PKR represented the most likely 
kinase responsible for this. We measured PKR phosphorylation in RSV infected cells and 
observed a significant increase over mock-infected cells. 
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After we determined that PKR is the likely kinase responsible for stress granule 
formation in RSV infection, we then attempted to inhibit activation of PKR and measure 
the effects on viral replication. We were able to use two reliable methods to accomplish 
this, treatment with the drug inhibitor, 2-AP, and knockdown of endogenous PKR 
expression. Treatment of infected cells with 2-AP effectively prevented the activation of 
PKR by RSV. Interestingly, we also observed a decrease in viral protein expression in 
cells that had been treated with 2-AP when compared to vehicle-treated cells. In addition, 
when we observed cells by indirect immunofluorescence, we noted a significant 
reduction in RSV infection in cells that had been treated with 2-AP when compared to 
vehicle-treated cells. We then measured the effect of drug treatment on viral titers. At 
each time-point measured, we detected a substantial decrease in cell-associated titer in 2-
AP treated cells versus vehicle-treated cells 
Our results demonstrating that 2-AP treatment inhibits PKR activation during 
RSV infection were quite exciting. However, given the possibility that 2-AP inhibits 
multiple targets, we sought to find another mechanism of PKR inhibition. To accomplish 
this, we generated a PKR knockdown cell line. These cells displayed an approximately 
90% decrease in total PKR expression. When we infected PKR knockdown cells with 
RSV, we did not detect phosphorylated PKR. When we compared viral titers between 
PKR knockdown cells and control cells we observed no difference in titers among the 
cell types. This was in contrast to our 2-AP data that suggests PKR activation is essential 
for efficient viral replication.  
To determine if the reduction in viral titers from  2-AP treatment was a result of 
an off-target effect, we repeated our 2-AP treatment experiments in the PKR knockdown 
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cell line. In these cells, we once again observed a significant decrease in RSV titers when 
compared to the control cell lines. Thus the inhibition of RSV replication by 2-AP was 
caused by an unknown, PKR-independent effect.  
Finally, we determined the effect of PKR knockdown on stress granule formation 
during RSV infection.  In PKR knockdown cells infected with RSV, we observed a 
significant reduction in infected cells that formed stress granules. We noted that the 
population of PKR knockdown cells was heterogenous for PKR expression. Taking this 
into account, we observed that most of the PKR knockdown cells that had formed stress 
granules generally had higher expression levels of PKR. These results confirm that PKR 
is the primary kinase activated by RSV that leads to the formation of stress granules. 
While we showed that RSV replicates poorly in G3BP-knockdown cells deficient 
for stress granule formation, we also showed that RSV replication is unaffected in PKR-
knockdown cells that similarly are deficient for stress granule formation. One possible 
explanation for this discrepancy is that knockdown of G3BP has unknown consequences 
besides inhibiting stress granule formation. Thus, viral replication could be inhibited by 
an alternate effect of this knockdown. Another possibility however, requires more 
thought. As I mentioned in Chapter I, stress granules appear to play a role in preventing 
or delaying apoptosis in stressed cells. A number of studies have shown that cells 
incapable of forming stress granules have poorer survival rates upon exposure to a stress 
(Buchan and Parker, 2009). Thus, perhaps in our G3BP-knockdown cells, increased rates 
of apoptosis could prevent efficient spreading of the virus. In PKR-knockdown cells 
however, PKR signaling does not occur, preventing the cell from activating cell-intrinsic 
antiviral responses. The signaling pathway that would normally induce stress granules 
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and promote apoptosis is not activated and the virus replicates unhindered. A diagram of 
this model is shown in Figure 4-1. 
 
Future Directions 
 Our current understanding of stress granule function during viral infection is 
limited. The work I describe in this thesis utilizes basic and fundamental experiments that 
detail the formation and signaling involved in stress granule formation during RSV 
infection. However, I have not yet been able to determine the function of stress granules 
in this context. Therefore, I will outline a series of experiments to define a role for stress 
granules and the signaling pathway required for formation during RSV infection. 
 Some of the data in Chapters II and III have conflicting interpretations. In Chapter 
II, my experiments implicated a proviral role for stress granules during infection, since 
inhibition of stress granule formation resulted in decreased viral titers. However, in 
Chapter III, I showed that RSV replication was unchanged in cells deficient in PKR 
expression; stress granules also did not form in these cells. Thus, I propose an additional 
knockdown experiment to address this discrepancy. In Chapter II, I mentioned that I 
attempted in infect MEF TIA-1 knockout cells. This cell line, much like the G3BP 
knockdown line I generated, is deficient for stress granule formation. However, this cell 
line was not permissive for infection. To address whether the effect we observed on RSV 
replication is due to a lack of stress granule formation or a separate function of G3BP, I 
could perform a similar set of studies by knocking down TIA-1 expression.  shRNAs 
exist that will inhibit the expression of TIA-1 in transduced cells. I could generate this 
cell line and then measure RSV titers as compared to wild-type cells. I would also 
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Figure 4-1. Proposed model for stress granule function in RSV infection. (A) RSV 
infects wild-type cells, resulting in the activation of PKR and the formation of stress 
granules following phosphorylation of eIF2α. Stress granules inhibit apoptosis in these 
cells, which allows for efficient viral replication to occur. (B) In G3BP knockdown cells, 
PKR activation occurs but stress granules do not form. This results in an increased rate of 
apoptosis and poor cell viability. RSV cannot efficiently replicate in these cells. (C) In 
PKR knockdown cells, PKR activation does not occur. Stress granules do not form and 
apoptosis is not induced due to the inability of the cell to react to the viral stress. RSV 
replication is unaffected by this change. 
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measure stress granule formation in these cells to verify that they are deficient for their 
formation. If a similar defect in viral replication in TIA-1 knockdown cells as compared 
to G3BP knockdown cells was observed, then the evidence would more convincingly 
implicate a role for stress granules in the RSV life cycle. 
 Others have shown that RSV mutants induce stress granules in a higher 
percentage of cells than wild-type virus (Hanley et al., 2010). In these studies, the authors 
used a viral construct in which the 5ʹ trailer region was replaced with a sequence 
complementary to the 3ʹ leader region. When cells were infected with this virus, a 50% 
increase was observed in infected cells containing stress granules as compared to wild-
type virus. A mechanism for increased stress granule formation by this mutant virus was 
not determined. A likely possibility is that this mutant virus generates a greater 
abundance of dsRNA due to the mutations and structural changes in the genome. More 
dsRNA would likely result in greater activation of PKR, in turn causing a higher 
percentage of cells to form stress granules. To test this hypothesis, I would first compare 
PKR activation levels in cells infected by wild-type and mutant viruses. I would then 
infect wild-type and PKR knockdown cells with the mutant virus. I would expect to see 
stress granule formation reduced in mutant virus infected PKR knockdown cells to levels 
comparable to that of wild-type virus in wild-type cells. 
 In Chapter II, I attempted to define specific subcellular areas of viral replication. 
My experiments showed that RSV genomic RNA predominantly accumulates in viral 
inclusion bodies. While this was a very interesting observation, much work remains to be 
done to define the entire viral RNA life cycle. Although RNA accumulates in inclusion 
bodies, it is not known how the RNA traffics from the inclusion body to the apical 
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surface of infected cells so that it can be packaged into nascent virions. Our work 
examined static images of viral RNA at specific time points after infection. Live-cell 
imaging experiments would help track viral RNA as it is trafficked through the cell. Our 
laboratory currently has a number of GFP-tagged RSV proteins optimized for expression 
in human cells. One of these plasmids, such as RSV N, could be transfected into cells. 
These cells could then be infected with RSV followed by addition of the RSV-specific 
probe to living cells. This approach would allow visualization of inclusion bodies as well 
viral RNA in the living cells. We would be able to track the RNA as it moves through the 
cell. Based on the speed and direction of movement, these experiments might also reveal 
whether specific cellular machinery, such as the actin network or microtubules, is 
involved in viral RNA trafficking. 
 Another interesting set of experiments would be to track viral mRNA through 
cells. Our collaborators are currently attempting to provide specific probes to RSV 
mRNAs. Using experiments described in Chapter II and the approach above, we could 
track viral mRNA from sites of production to sites of translation. 
 My results in Chapter III show that the kinase inhibitor, 2-AP, greatly restricts 
RSV replication. Although I showed that the mechanism of viral inhibition was PKR 
independent, I did not identify the exact target of action of the drug. Experiments to 
identify other kinases that are inhibited by 2-AP could lead us to a critical mediator of the 
RSV replication. To address this possibility, a kinomic analysis could be performed. To 
perform this, I would vehicle-treat or 2-AP treat cells and inoculate with RSV, similar to 
the experiments performed in Chapter III. I would then prepare the cell lysates for each 
condition and use a kinase array to determine differences in kinase functionality (Bowick 
 82	  
et al., 2006) and (Johnson and Hunter, 2005). Ideally, I would be able to identify a few 
major changes in kinase function and then attempt to determine the role of each target in 
RSV infection. Alternatively, if I found many changes in kinase activity, I could group 
kinase activity according to specific pathways using Ingenuity Pathway Analysis. This 
would allow me to identify broad changes in cellular signaling induced by RSV. 
 PKR production and function is closely tied to type I interferon activation. 
Interferon α/β signaling is the primary method by which cells upregulate PKR expression 
during infection. RSV inhibits the host interferon response through expression of the NS1 
and NS2 proteins, which block interferon signaling (See Chapter I). Therefore, although I 
observe PKR induction and activation in RSV-infected cells, perhaps the virus actively 
limits PKR function. NS1 and NS2 deletion viruses exist and are able to replicate; 
however, they are severely limited in this capacity compared to wild-type virus. I propose 
that NS1 and NS2 viruses are poorly infectious due to the fact that they more robustly 
activate PKR signaling, allowing cells to more effectively combat infection. To test this 
hypothesis, I would infect wild-type cells with NS1 deletion virus, NS2 deletion virus, or 
wild-type RSV. I would then measure and compare the levels of PKR expression and 
activation between each virus. Further, I would also measure titers for each virus in the 
PKR knockdown cell line I generated in Chapter III. I hypothesize that the NS1 and NS2 
deletion viruses can grow to equal levels compared to that of wild-type virus in the PKR 
knockdown cells. These data would clarify whether increased activation of PKR is the 
limiting factor of NS1 and NS2 gene deletion viruses. 
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Respiratory syncytial virus (RSV) infects polarized epithelia, which
have tightly regulated trafficking because of the separation and
maintenance of the apical and basolateral membranes. Previously
we established a link between the apical recycling endosome (ARE)
and the assembly of RSV. The current studies tested the role of a
major ARE-associated protein, Rab11 family interacting protein 2
(FIP2) in the virus life cycle. A dominant-negative form of FIP2
lacking its N-terminal C2 domain reduced the supernatant-associ-
ated RSV titer 1,000-fold and also caused the cell-associated virus
titer to increase. These data suggested that the FIP2 C2 mutant
caused a failure at the final budding step in the virus life cycle.
Additionally, truncation of the Rab-binding domain from FIP2
caused its accumulation into mature filamentous virions. RSV
budding was independent of the ESCRT machinery, the only
well-defined budding mechanism for enveloped RNA viruses.
Therefore, RSV uses a virus budding mechanism that is controlled
by FIP2.
Pneumovirinae  Rab11 protein  virus replication  virus shedding
Respiratory syncytial virus (RSV) is the most common viralcause of serious lower respiratory tract illness in infants and
children worldwide. RSV is a negative-sense, single-stranded
RNA virus of the Paramyxoviridae family, which encodes 11
proteins. Infection is limited to the most superficial layer of
polarized ciliated cells in the respiratory tract epithelium, en-
tering through the apical surface (1, 2). Late steps of the RSV
life cycle include assembly and budding of the virus, which also
occur at the apical membrane in polarized cells (3).
RSV virions are pleomorphic, with a spherical form varying in
size from 150 to 250 nm in diameter. The filamentous form of the
virus has a smaller diameter of 50 nm and can have a length from
1 to 10microns, depending on the cell line in which virus is grown
(4). Filamentous RSV has been observed budding and fusing
with cells during the spread of RSV infection (5). These long
filaments destabilize into spherical forms that can be similar to
the size of spherical particles collected during infection (4).
Other related viruses also make filamentous virions such as
influenza, Ebola, and parainfluenza viruses (6, 7, 8). In polarized
cell culture monolayers, influenza virus is predominantly fila-
mentous, and this filamentous form has a higher specific infec-
tivity (9). A previous analysis of the RSV cell-surface filaments
in live infected cells showed that these filaments are dynamic,
demonstrating rotation, directed motion, and diffusion (10).
The minimal viral protein requirements for budding of RSV
virus-like particles (VLPs) are fusion (F), matrix (M), nucleo-
protein (N), and phosphoprotein (P) (11). The F protein follows
the secretory pathway through the endoplasmic reticulum and
Golgi and is directed to the apical membrane through a lipid
raft-associated mechanism (12). The other viral structural pro-
teins and the RNA genome must also traffic to the apical
membrane from the cytoplasm and viral inclusion bodies
through an undetermined mechanism. Lipid rafts have been
associated with the assembly of RSV virions, possibly as sites of
coordinated assembly, yet the mechanism by which membrane
microdomains function during budding remains obscure (12, 13).
Polarized epithelial cells exhibit a complex distribution of
proteins that is maintained by a polarized cytoskeleton and a
series of discrete endosomal compartments. The apical recycling
endosome (ARE) is located just below the apical membrane and
is marked by the presence of Rab11a (14). The ARE serves as
a slow recycling endosome as well as the final destination for
basolateral to apical membrane transcytosing proteins (15). A
number of Rab11-interacting proteins have been identified to
date including myosin Vb (MVb) and the Rab11 family inter-
acting proteins (Rab11-FIPs) (16, 17). Previously, we have shown
that if a dominant-negative form of MVb is present, then RSV
does not assemble properly at the apical membrane (18).
In the current study, we analyzed the role of another Rab11
interacting protein, Rab11-FIP2 (FIP2), in the RSV life cycle
(Fig. 1A). FIP2 domains include an N-terminal C2 domain that
binds preferentially to membrane lipids (19), a central MVb-
binding domain (20), three NPF motifs (21), and a C-terminal
Rab-binding domain (RBD) that is conserved among all FIPs
(16, 22). We now demonstrate that expression of a dominant-
negative form of the FIP2 protein lacking the C2 domain
(FIP2-C2) in polarized Madin–Darby canine kidney (MDCK)
cells blocks RSV budding, causing retention of assembled virus
on infected cells. Additionally, inhibition of the previously
identified major mechanism of RNA virus budding, the ESCRT
machinery, did not affect virus titers. These results suggest that
RSV uses an RNA-enveloped virus budding mechanism con-
trolled by FIP2.
Results
FIP2 Function Is Necessary for RSV Production. MDCK cell lines
expressing FIP2 variants under doxycycline repression were
tested to determine whether dominant-negative forms of FIP2
would alter RSV replication. Expression of the FIP2 variants had
no observable effect on cell viability. Tight control of FIP2
variant expression and relative expression levels are shown in
Fig. 1C. As expected, expression of FIP2-WT did not affect RSV
supernatant titer measured at 5 days after infection (Fig. 1B).
Expression of a mutant lacking the RBD (FIP2-RBD) also did
not inhibit the RSV supernatant titer. In contrast, a mutant that
lacks the C2 domain (FIP2-C2) reduced the RSV titer1,000-
fold. None of the three FIP2 variants affected vaccinia virus
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replication (Fig. 1B and data not shown). There was no reduction
in entry or viral RNA production in the FIP2-C2 cells as
measured by fluorescent focus or real-time RT-PCR assays (data
not shown).
Production of RSVWas Delayed and Reduced.To determine whether
the reduction of virus shedding observed at day 5 was an effect
of delayed kinetics or reduced magnitude, we performed a 7-day
growth curve. Supernatant and cell-associated fractions were
collected daily and RSV titer measured by plaque assay. There
was no alteration in RSV kinetics in the presence of FIP2-WT
(Fig. 2A). In contrast, when FIP2-C2 was expressed, the time
to achieve 50% maximal peak titer of budded virus was delayed
by 2 days, and the titer was reduced by 10- to100-fold over the
first 5 days (Fig. 2B). Although production of RSV was delayed
and reduced, the peak titer still occurred on day 5, followed by
a steep decline of RSV titer.
RSV Accumulates on the Cell in the Presence of FIP2-C2. The titer of
RSV in the cell-associated fraction was measured simultaneously
with that in the supernatant fraction. There was no alteration in
viral kinetics when FIP2-WT was expressed (Fig. 2C). Interest-
ingly, when FIP2-C2 was expressed, there was an increase in
cell-associated, viral titer through day 6 (Fig. 2D). This statisti-
cally significant accumulation of RSV suggested that the FIP2-
C2 block occurs at a late budding step. This phenotype differs
dramatically from that observed with the previous MVb-tail
experiments in which the cell-associated fractions were de-
creased in titer 10,000-fold (18). Therefore, MVb acts earlier
than FIP2 in the assembly and budding process of RSV.
Apical Filaments Are Fully Assembled Virus Structures. We deter-
mined the location of the structural proteins required for
budding. The four necessary major structural proteins (F, M, N,
and P) were localized to cell-surface filaments in both nonex-
pressing (data not shown) and FIP2-C2-expressing, RSV-
infected cells [supporting information (SI) Fig. S1]. Molecular
beacon RNA probes specific for the RSV gene-start consensus
sequence were used to identify the viral genomic RNAwithin the
viral filaments. These data suggested that cell-surface filaments
in RSV-infected FIP2-C2-expressing cells are assembled, in-
fectious, late-stage viral particles. Additionally, to determine
whether these viral structures contained cytoskeletal elements,
we stained infected cells for actin, microtubules, and ezrin (Fig.
S2). None of these proteins were present in the viral filaments
for either nonexpressing or expressing FIP2-C2 cell lines. We
repeated the actin localization studies by using visualization of
a YFP-actin fusion construct or by using actin-specific antibod-
ies, both of which confirmed the absence of actin from viral
filaments (data not shown).
FIP2-C2-Mediated Viral Inhibition Induced a Tethered Late-Domain-
Like Phenotype. To determine how FIP2-C2 affected the mor-
phology of RSV budding from the apical membrane of polarized
cells, we used scanning EM to visualize the viral filaments.
Typically the filaments were 1–3 m in length on the apical
surface of infected MDCK cells (Fig. 3A). Microvilli, usually
0.5 m in length, were observed in surrounding uninfected
cells. When the MVb-tail mutant was expressed, we observed a
loss of viral filaments from the apical plasma membrane, which
was expected because of the known preassembly block (Fig. 3B).
Finally, when FIP2-C2 was expressed, we observed a significant
elongation of viral filament length to3–10 m, suggesting that
the filamentous virions were unable to undergo the fission
process and continued to extend in length (Fig. 3 D and E). This
cell morphology is markedly different from that of an uninfected
monolayer expressing FIP2-C2 (Fig. 3C).
The RSV Budding Mechanism Is Vps4-Independent. The primary
mechanism for budding used by many enveloped RNA viruses is
through hijacking the host ESCRT machinery, which is respon-
sible for multivesicular body formation (23). UsingWTVps4a or
each of the two dominant-negative Vps4a mutants K173Q or
E228Q transfected into 293T cells, we tested whether RSV used
this machinery for assembly and budding. No reduction of RSV
titer was observed in the presence of either WT or dominant-
negative Vps4a mutants (Fig. 4A). In contrast, a HIV
pseudotyped with vesicular stomatitis virus (VSV) G protein
(HIVNL4-3), exhibited 90% reduced supernatant p24 levels in
the presence of the dominant-negative Vps4a constructs, as
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expected (Fig. 4A). Experiments with similar Vps4b constructs
also yielded the same results (Fig. 4B). The ubiquitination cycle
is important for many viruses that use late domains (L-domains).
However, three separate proteasome inhibitors did not affect
budded RSV titers (Fig. S3D), again suggesting that RSV
assembly and budding uses a mechanism independent of the
ESCRT machinery.
Addition of Strong L-Domains to RSV M Did Not Render RSV Sensitive
to Vps4a. To determine whether RSV possesses a cryptic or weak
L-domain, we introduced the L-domain from the paramyxovirus
PIV5 into the RSV M protein. A second mutant construct was
made by adding the first 13 aa of the Ebola VP40 protein
(containing a functional L-domain) to the N terminus of RSVM
protein (Fig. S3A). These proteins were expressed in cells during
RSV infection. Neither of the variant M proteins affected the
magnitude of budded or cell-associated virus (Fig. S3B). Addi-
tionally, coexpression of the M protein variants in infected cells
with WT Vps4a or either of the two dominant-negative Vps4a
mutants did not affect RSV titer of supernatant or cell-
associated virus (Fig. S3C and data not shown, respectively).
These data further indicated that the FIP2-C2 block of RSV
budding is independent of the ESCRT machinery.
FIP2 Variants Localize with Viral Structures. Next we determined
whether FIP2 localized with viral structures. Infected cell mono-
layers expressing FIP2-WT, FIP2-C2, or FIP2-RBD were
stained for viral filaments (marked by RSV F protein) and viral
inclusions (marked by RSV N protein). FIP2-WT showed 55%
colocalization with viral inclusion bodies and little localization
with viral filaments (Fig. 5). FIP2-C2-containing tubulovesicu-
lar membranes appeared to be docked with viral inclusions, and
colocalization was reduced to 13%. FIP2-RBD also demon-
strated colocalization with viral inclusion bodies (21% greater
than FIP2-C2, P  0.009), but removal of the RBD caused a
relocalization to the viral filaments (31%, P  0.0001). Finally,
when MDCK cells were infected with recombinant RSV, which
expresses GFP in the cytoplasm, GFP was excluded from viral
filaments (Fig. 5). These data suggest that truncation of the RBD
blocks the cycling of FIP2 away from the apical membrane,
causing it to assemble into RSV filaments.
Discussion
In this study we sought to define the role of the ARE in late steps
of the RSV life cycle. Using a panel of FIP2 mutant-expressing
MDCK cells, we determined that FIP2 is required at a late stage
of RSV budding, most likely fission. Our studies show RSV does
not use a Vps4-dependent virus budding mechanism, indicating
that FIP2 acts in a previously uncharacterized pathway for
enveloped virus budding.
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Fig. 3. FIP2 facilitates termination of RSV filament growth and virus bud-
ding. (A, B, D, and E) Scanning EM was performed to view the length of RSV
filaments at the apical surface of MDCK cells expressing FIP2-WT, a dominant
negative (A), an MVb-tail construct (B), or FIP2-C2 (D or E) (images from
separate cells at two resolutions). (C) Uninfected cells expressing FIP2-C2.
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It has been shown that RSV is released from the apical
surface in polarized cells, and the minimal requirements for
virus-like particle formation are the RSV F, M, N, and P
proteins (11). We observed all four proteins and the RSV
genome in the viral filaments. In addition, when these viral
proteins were cotransfected, we observed predominantly fila-
mentous structures at the surface of cells (data not shown).
Studies testing the effect of inhibitors of RSV have shown that
loss of supernatant virus titer coincides with loss of surface
filaments (24, 25). Not only does this study show that FIP2
controls fission of surface filaments, but the data also suggest
that these filaments are virion particles.
It has been speculated that the filamentous structures at the
surface of RSV-infected cells are actin-based structures (26, 27),
yet our studies show that neither actin nor apical microvilli-
associated proteins are present in the filaments. These findings
do not eliminate the possibility that actin coordinates the
assembly of virus at the base of filaments. In fact, some viral
filaments appeared to be extensions of polymerized actin struc-
tures. High-resolution EM studies have recently suggested that
the cortical actin network may be linked to the base of these viral
filaments (28). Additionally, the lack of free diffusion of cyto-
plasmic GFP into filaments indicated that these viral filaments
are specifically and tightly packaged, not passively filled tubular
structures.
The only previously well delineated mechanism responsible
for negative-sense RNA virus budding is the hijacking of the
ESCRT machinery. The ESCRT mechanism of viral trafficking
and virion formation is governed by viral proteins containing
L-domains. RSV proteins do not contain any identifiable L-
domains. Budding through the use of such L-domains depends
on the AAA-ATPase Vps4. When dominant-negative forms of
Vps4 are expressed in cells infected with viruses containing
L-domains, virions appear to be tethered to the membrane
through a thin stalk because of a loss of fission (23, 29). We
studied RSV infection in cells expressing the Vps4a and Vps4b
dominant-negative proteins and found there was no reduction in
virus budding.
Unlike many viruses, infectious RSV virions are predomi-
nantly cell-associated in culture. This observation suggests that
either RSV contains an inefficient L-domain or uses an unde-
scribed budding mechanism that is less efficient. Therefore, we
engineered recombinant forms of the RSV M protein that
contained either the Ebola virus VP40 L-domain or the L-
domain of the related paramyxovirus PIV5 (30, 31). Although
L-domains are able to act in a location-independent manner, we
inserted the sequences at positions similar to other viruses (32).
Overexpression of these altered M proteins in cells during WT
RSV infection did not increase budding or render RSV sensitive
to the dominant-negative Vps4a proteins, suggesting that an
inefficient or occult RSV L-domain is not a determining factor
in the RSV budding pathway. A caveat of this interpretation is
that WT M protein expressed by the virus was also present in
cells. Although not entirely comparable, it has been shown that
insertion of the Ebola virus L-domain into VSV M protein
altered VLP budding (33).
Many viruses require ubiquitination for entry into the ESCRT
pathway, although this correlation does not exist for all viruses.
VSV is sensitive to proteasome inhibitors but does not appear to
be sensitive to the dominant-negative Vps4a protein (33).
Equine infectious anemia virus contains a Vps4a-dependent
L-domain but is not sensitive to proteasome inhibitors (34). In
our studies, RSV budding was not inhibited by proteasome
inhibitors, suggesting that the FIP2-associated budding machin-
ery belongs to a third category of budding mechanisms that is
both Vps4-independent and ubiquitination-independent. Recent
studies have demonstrated that both human cytomegalovirus
and Semliki Forest virus budding also are independent of Vps4
and ubiquitination (35, 36). It will be interesting to determine
whether the FIP2 mechanism, like ESCRT, is a common mech-
anism used by other enveloped viruses.
Analysis to determine whether FIP2 associated with viral
structures demonstrated a significant localization with viral
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inclusion bodies yet little apparent localization in viral filaments.
This finding may be due to a low concentration required for
function at the base of the filaments or a fast recycling rate. The
dynamics of FIP2 recycling are demonstrated by the wide spread
of values for localization of FIP2-WT with viral inclusion bodies.
Further analysis of the FIP2 truncation mutants demonstrated
that removal of the C2 domain blocked colocalization, yet viral
inclusions appear to be docked to FIP2-C2-containing vesicles.
FIP2-C2 expression blocks transcytosis from the basal to apical
membrane at a transitional step between the common endosome
and ARE (37). Together these findings indicate that the asso-
ciation of FIP2 with the viral inclusion body depends on endo-
somal transcytotic trafficking events through the ARE that
occur after passage through the common endosome.
The other FIP2 truncation mutant, FIP2-RBD, localized
with both cytoplasmic viral inclusion bodies and apical viral
filaments. These data suggest that the RBD is required for the
recycling of FIP2 from the apical membrane back to the ARE
and the viral inclusion body. Thus the dissociation of FIP2-
RBD fromRab11-dependent recycling allowed FIP2-RBD to
assemble into viral filaments. The RBD of FIP2 is required not
only for binding Rab11 but also for homodimerization (21). The
lack of FIP2-RBD inhibition of RSV budding indicates that
FIP2 may have functions independent of dimerization and
Rab11 binding (38).
EM analysis of viral inclusion bodies suggest that they are not
membrane-bound structures (39). Removal of the RBD also
blocks the Rab-dependent association with membranes at the
ARE through Rab myristoylation, which causes a cytoplasmic
diffuse localization of FIP2-RBD in the absence of infection
(21). The localization of FIP2-RBD and FIP2-WT to viral
inclusion bodies suggests that FIP2 may also function in traf-
ficking nonmembrane-bound cargo.
If this budding mechanism proves to be as complex as the
ESCRT mechanism, FIP2 may be only one host protein from a
large group of host proteins functioning together to facilitate
virus budding. Current proteomic analysis of ARE vesicles is
targeted at discovering this remaining host machinery involved
in late steps of the RSV assembly and budding pathway. It is
tempting to speculate that the mechanism hijacked by RSV may
be an ARE-regulated mechanism for cellular deflagellation or
shedding of microvilli because the N complex in filamentous
virions mimics the periodicity of actin in microvilli or tubulin in
cilia (4, 40).
Materials and Methods
Mammalian Cell Lines and Virus. MDCK T23 cell lines (Clontech) expressing
tetracycline-repressible WT or mutant human EGFP-FIP2 were constructed
as described (37). Suppression or induction of FIP2-GFP F protein expression
was regulated by the presence or absence of 20 ng/ml doxycycline. MDCK
and HEp-2 cell lines were maintained as described (18). The 293T cells were
grown in DMEM and Ham’s F-12 medium supplemented with 10% FBS, 320
g/ml L-glutamine, 1% (vol/vol) nonessential amino acids, 2.7 g/ml am-
photericin B, and 45 g/ml gentamicin. All cell lines were maintained at
37°C in 5% CO2. The RSV WT strain A2 (41), recombinant RSV-GFP (42),
VSV-G-pseudotyped HIVNL4-3 (43), and vaccinia virus strain Western Reserve
have been described (18).
Viral Infection Assay.Cells were seeded in triplicate onto 48-well tissue
culture plates (Costar) at 20% confluence and allowed to form fully-
confluent cell monolayer cultures in the presence or absence of doxycycline
to control expression of GFP-FIP2 variant proteins. Once confluent, the cell
culture monolayers were inoculated with RSV at a multiplicity of infection
(moi) of 0.25 plaque-forming units per cell. Virus was allowed to adsorb for
1 h at 37°C. After adsorption, virus infection medium was removed, tissue
culture wells were washed three times with PBS, and 300 l of growth
medium (with or without doxycycline) was added. Infected cells were
incubated at 37°C in 5% CO2.
Virus Recovery and Titration. Tissue culture supernatant containing virus was
collected and brought to a volume of 300 l. After the collection of the
supernatant fraction, tissue culture wells were washed three times with 250l
of PBS. Cell-associated virus was harvested by scraping MDCK cell culture
monolayers into 150 l of medium, followed by an additional washing of the
well with 150 l of medium. Virus was released from harvested cells by using
rapid freeze–thaw with movement between an ethanol dry-ice bath and a
37°C water bath, which was repeated three times. Recovered RSV was quan-
tified by plaque assay as described (44). HIV p24 assay was performed as
described (43). Vaccinia virus titer was quantified by plaque assay on BSC-40
cell monolayers, followed by staining with crystal violet (18).
Transfection. Forty micrograms of DNA was added to 2.5 M calcium chloride,
followed by dropwise addition of 2 BBS. This solution was incubated for 25
min and then added dropwise to 293T cells plated at 40% confluency in 10-cm
dishes, followed by 24 h of incubation at 35°C in 3% CO2. Transfected cells
were washed with PBS and fresh DMEM and Hanks’ F-12 medium was added.
Transfection efficiency was assessed by visual inspection using microscopy
with epifluorescence. Cells were inoculated with RSV at a moi of 5 on day 3
after transfection. RSV M protein variants were transfected into HEp-2 cells by
using Effectene (Qiagen) with or without Vps4a constructs and then infected
with RSV at an moi of 0.25 at 24 h after transfection.
Scanning EM.MDCK cells (with or without doxycycline) were seeded on 12-mm
cover slips in 24-well plates. Cells were infected with RSV at a moi of 0.25 as
described above. Samples were fixed 24 h after infection in 4% glutaralde-
hyde (Sigma) in 0.1 M cacodylate buffer (Sigma), treated with 1% osmium
(Sigma), and dehydrated through a series of 70–100% ethanol washes. De-
hydrated cells were critical-point dried, sputter-coated with gold, and visual-
ized by using a Hitachi S4200 scanning electron microscope.
Fluorescence Assays. A molecular beacon molecule specific for the RSV
genome at 1 mM was delivered by using transient permeablization with
streptolysin O of live infected cells as described (10). Cells were fixed by
using 3.7% formaldehyde (Sigma) in PBS, followed by 3.7% formaldehyde
with 0.3% Triton X-100 (Sigma) in PBS. Cells were blocked by using 3% BSA
(Sigma) and then stained with a primary antibody against F (palivizumab;
MedImmune), M (clone B135), N (clone B130), P (clone 4.14.4), ezrin
(Sigma), or -tubulin (AbCam) in block. Cells were washed, and then
antibodies were conjugated with Alexa Fluor 568 or 647 and/or phalloidin
647 (Invitrogen) in block were added. Slides were mounted by using
ProLong Antifade (Invitrogen). Images were acquired on a Zeiss LSM 510
Meta confocal microscope. Analysis of colocalization was performed by
using MetaMorph 7.1 software (Molecular Devices) on 21 fields from three
separate assays. Western blot analyses were performed by using NuPAGE
reagents (Invitrogen) following the manufacturer’s instructions. Primary
antibodies were against GFP (Clontech) or -actin (AbCam). Secondary
antibody was goat anti-mouse conjugated to HRP (KPL), followed by
visualization with Chemiluminescent Substrate (Pierce).
Proteasome Inhibitor Assays.MG-132, lactacystin, and epoxomicin (EMD) were
dissolved in DMSO (Sigma) and used within 2 weeks at a final concentration
of 1.0M. HEp-2 cells were infected with either HIVNL4-3 or RSV at a moi of 2.0.
Fresh media with inhibitor or DMSO vehicle were added 24 h after infection.
Virus was collected 48 h after infection.
PCR Mutagenesis of RSV M Protein. A cDNA encoding the RSV strain A2 M
protein was sequence-optimized for mammalian expression and synthe-
sized by GENEART (designated Mopt). L-domain sequences from Ebola virus
VP40 protein (amino acids PTAPPEY) or PIV5 M protein (amino acids FPIV)
were designed for integration into, or as an addition to, the M sequence.
PCR extension was performed to generate the chimeric RSV M proteins,
designated RSV Mopt-EbV or Mopt-PIV5; primers are available upon request.
All constructs were cloned into the Invitrogen plasmid vector pcDNA3.1(	)
with restriction sites 5
-BamHI-EcoRI-3
.
ACKNOWLEDGMENTS. We thank Sarah Sewell for assistance with the SEM
and Natalie Thornburg for assistance with Vaccinia experiments. Confocal
microscopy and SEM experiments were performed in part through the use
of the Vanderbilt University Medical Center Cell Imaging Shared Resource.
We thank Wes Sundquist (Department of Biochemistry, University of Utah,
Salt Lake City) for the Vps4 DNA constructs and Peter Collins (National
Institute of Allergy and Infectious Disease, National Institutes of Health,
Utley et al. PNAS  July 22, 2008  vol. 105  no. 29  10213
M
IC
RO
BI
O
LO
G
Y
Bethesda, MD) and Mark Peeples (Center for Vaccines and Immunity, The
Research Institute at Nationwide Children’s Hospital, Columbus, OH) for
RSV-GFP. J.E.C. holds a Clinical Scientist Award in Translation Research from
the Burroughs Wellcome Fund. This work was supported by National
Institutes of Health (NIH) Training Grant T32 GM08554 (to T.J.U.) and NIH
Grant DK48370 (to J.R.G.).
1. Wright PF, et al. (2005) Growth of respiratory syncytial virus in primary epithelial cells
from the human respiratory tract. J Virol 79:8651–8654.
2. Zhang L, Peeples ME, Boucher RC, Collins PL, Pickles RJ (2002) Respiratory syncytial virus
infection of human airway epithelial cells is polarized, specific to ciliated cells, and
without obvious cytopathology. J Virol 76:5654–5666.
3. Roberts SR, Compans RW, Wertz GW (1995) Respiratory syncytial virus matures at the
apical surfaces of polarized epithelial cells. J Virol 69:2667–2673.
4. Bachi T, Howe C (1973) Morphogenesis and ultrastructure of respiratory syncytial virus.
J Virol 12:1173–1180.
5. Bachi T (1988) Direct observation of the budding and fusion of an enveloped virus by
video microscopy of viable cells. J Cell Biol 107:1689–1695.
6. Ellis DS, et al. (1978) Ultrastructure of Ebola virus particles in human liver. J Clin Pathol
31:201–208.
7. Mosley VM, Wyckoff RWG (1946) Electron micrography of the virus of influenza.
Nature 157:263.
8. Yao Q, Compans RW (2000) Filamentous particle formation by human parainfluenza
virus type 2. J Gen Virol 81:1305–1312.
9. Ada GL, Perry BT, Edney M (1957) Infectivity of influenza virus filaments. Nature
180:1134.
10. Santangelo PJ, Bao G (2007) Dynamics of filamentous viral RNPs prior to egress.Nucleic
Acids Res 35:3602–3611.
11. Teng MN, Collins PL (1998) Identification of the respiratory syncytial virus proteins
required for formation and passage of helper-dependent infectious particles. J Virol
72:5707–5716.
12. Brown G, et al. (2004) Analysis of the interaction between respiratory syncytial virus
and lipid-rafts in HEp2 cells during infection. Virology 327:175–185.
13. McCurdy LH, Graham BS (2003) Role of plasma membrane lipid microdomains in
respiratory syncytial virus filament formation. J Virol 77:1747–1756.
14. Casanova JE, et al. (1999) Association of Rab25 and Rab11a with the apical recycling
system of polarized Madin–Darby canine kidney cells. Mol Biol Cell 10:47–61.
15. Apodaca G, Katz LA, Mostov KE (1994) Receptor-mediated transcytosis of IgA in MDCK
cells is via apical recycling endosomes. J Cell Biol 125:67–86.
16. Hales CM, et al. (2001) Identification and characterization of a family of Rab11-
interacting proteins. J Biol Chem 276:39067–39075.
17. Lapierre LA, et al. (2001) Myosin vb is associated with plasma membrane recycling
systems. Mol Biol Cell 12:1843–1857.
18. Brock SC, Goldenring JR, Crowe JE, Jr (2003) Apical recycling systems regulate direc-
tional budding of respiratory syncytial virus from polarized epithelial cells. Proc Natl
Acad Sci USA 100:15143–15148.
19. Lindsay AJ, McCaffrey MW (2004) The C2 domains of the class I Rab11 family of
interacting proteins target recycling vesicles to the plasma membrane. J Cell Sci
117:4365–4375.
20. Hales CM, Vaerman JP, Goldenring JR (2002) Rab11 family interacting protein 2
associates with Myosin Vb and regulates plasma membrane recycling. J Biol Chem
277:50415–50421.
21. Cullis DN, Philip B, Baleja JD, Feig LA (2002) Rab11-FIP2, an adaptor protein connecting
cellular components involved in internalization and recycling of epidermal growth
factor receptors. J Biol Chem 277:49158–49166.
22. Meyers JM, Prekeris R (2002) Formation of mutually exclusive Rab11 complexes with
members of the family of Rab11-interacting proteins regulates Rab11 endocytic tar-
geting and function. J Biol Chem 277:49003–49010.
23. Garrus JE, et al. (2001) Tsg101 and the vacuolar protein sorting pathway are essential
for HIV-1 budding. Cell 107:55–65.
24. Gower TL, et al. (2005) RhoA signaling is required for respiratory syncytial virus-induced
syncytium formation and filamentous virion morphology. J Virol 79:5326–5336.
25. Oomens AG, Bevis KP, Wertz GW (2006) The cytoplasmic tail of the human respiratory
syncytial virus F protein plays critical roles in cellular localization of the F protein and
infectious progeny production. J Virol 80:10465–10477.
26. Fernie BF, Gerin JL (1982) Immunochemical identification of viral and nonviral proteins
of the respiratory syncytial virus virion. Infect Immun 37:243–249.
27. Ulloa L, Serra R, Asenjo A, Villanueva N (1998) Interactions between cellular actin and
human respiratory syncytial virus (HRSV). Virus Res 53:13–25.
28. Jeffree CE, et al. (2007) Ultrastructural analysis of the interaction between F-actin and
respiratory syncytial virus during virus assembly. Virology 369:309–323.
29. Mebatsion T, Weiland F, Conzelmann KK (1999) Matrix protein of rabies virus is
responsible for the assembly and budding of bullet-shaped particles and interacts with
the transmembrane spike glycoprotein G. J Virol 73:242–250.
30. Licata JM, et al. (2003) Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40
protein function independently as late budding domains: Involvement of host proteins
TSG101 and VPS-4. J Virol 77:1812–1819.
31. Schmitt AP, Leser GP, Morita E, Sundquist WI, Lamb RA (2005) Evidence for a new viral
late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. J Virol
79:2988–2997.
32. Yuan B, Campbell S, Bacharach E, Rein A, Goff SP (2000) Infectivity of Moloney murine
leukemia virus defective in late assembly events is restored by late assembly domains
of other retroviruses. J Virol 74:7250–7260.
33. Irie T, Licata JM, McGettigan JP, Schnell MJ, Harty RN (2004) Budding of PPxY-
containing rhabdoviruses is not dependent on host proteins TGS101 and VPS4A. J Virol
78:2657–2665.
34. Patnaik A, Chau V, Li F, Montelaro RC, Wills JW (2002) Budding of equine infectious
anemia virus is insensitive to proteasome inhibitors. J Virol 76:2641–2647.
35. Fraile-Ramos A, et al. (2007) The ESCRT machinery is not required for human cytomeg-
alovirus envelopment. Cell Microbiol 9:2955–2967.
36. Taylor GM, Hanson PI, Kielian M (2007) Ubiquitin depletion and dominant-negative
VPS4 inhibit rhabdovirus budding without affecting alphavirus budding. J Virol
81:13631–13639.
37. Ducharme NA, et al. (2007) Rab11-FIP2 regulates differentiable steps in transcytosis.
Am J Physiol Cell Physiol 293:C1059–C1072.
38. Ducharme NA, et al. (2006) MARK2/EMK1/Par-1B alpha phosphorylation of Rab11-
family interacting protein 2 is necessary for the timely establishment of polarity in
Madin–Darby canine kidney cells. Mol Biol Cell 17:3625–3637.
39. Garcia J, Garcia-Barreno B, Vivo A, Melero JA (1993) Cytoplasmic inclusions of respi-
ratory syncytial virus-infected cells: Formation of inclusion bodies in transfected cells
that coexpress the nucleoprotein, the phosphoprotein, and the 22K protein. Virology
195:243–247.
40. Norrby E, Marusyk H, Orvell C (1970) Morphogenesis of respiratory syncytial virus in a
green monkey kidney cell line (Vero). J Virol 6:237–242.
41. Coates HV, Alling DW, Chanock RM (1966) An antigenic analysis of respiratory syncytial
virus isolates by a plaque reduction neutralization test. Am J Epidemiol 83:299–313.
42. Hallak LK, Spillmann D, Collins PL, Peeples ME (2000) Glycosaminoglycan sulfation
requirements for respiratory syncytial virus infection. J Virol 74:10508–10513.
43. Varthakavi V, et al. (2006) The pericentriolar recycling endosome plays a key role in
Vpu-mediated enhancement of HIV-1 particle release. Traffic 7:298–307.
44. Murphy BR, Sotnikov AV, Lawrence LA, Banks SM, Prince GA (1990) Enhanced pulmo-
nary histopathology is observed in cotton rats immunized with formalin-inactivated
respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3–6
months after immunization. Vaccine 8:497–502.
10214  www.pnas.orgcgidoi10.1073pnas.0712144105 Utley et al.
	   90	  
 
 
 
 
APPENDIX B	  
Single molecule–sensitive
probes for imaging RNA in
live cells
Philip J Santangelo1, Aaron W Lifland1, Paul Curt1,
Yukio Sasaki2, Gary J Bassell2, Michael E Lindquist3 &
James E Crowe Jr3,4
To visualize native or non-engineered RNA in live cells with
single-molecule sensitivity, we developed multiply labeled
tetravalent RNA imaging probes (MTRIPs). When delivered with
streptolysin O into living human epithelial cancer cells and
primary chicken fibroblasts, MTRIPs allowed the accurate
imaging of native mRNAs and a non-engineered viral RNA, of
RNA co-localization with known RNA-binding proteins, and of
RNA dynamics and interactions with stress granules.
Currently researchers use a vast excess of probes or plasmid-derived
RNA to image RNA with single-molecule sensitivity. Either both
the RNA and probe are expressed from a plasmid, requiring
binding of up to 48 MS2-GFP1,2 molecules, or just the RNA is
expressed from a plasmid, requiring binding sites for 96 molecular
beacon probes3 to achieve single-molecule sensitivity. As plasmid-
derived RNA restricts usage to cell types that can be efficiently
transfected and is susceptible to artifacts
caused by overexpression, imaging native
RNA is preferred, but requires a more
sensitive probe to achieve single-molecule sensitivity with a limited
number of bound probes. We designed multiply labeled tetravalent
RNA imaging probes (MTRIPs) composed of a 2¢-O-methyl RNA-
DNA chimera nucleic acid ligand with four or five amino-modified
thymidines, 5¢ biotin modification and a short (5–7-base) poly(T)
sequence to extend the ligands from the surface of streptavidin. We
used the amino-modified thymidines to conjugate N-hydroxy-
succinimide (NHS) ester–modified fluorophores to the ligand. On
average, each ligand was labeled with three fluorophores, limiting
self-quenching. We chose fluorophores with quantum yields above
65% and they exhibited little triplet state excitation. The multiply
labeled monovalent ligands were tetramerized via their binding to
streptavidin, which increased probe brightness fourfold (Fig. 1a).
MTRIPs, when delivered via reversible cell membrane permeabiliza-
tion4 with streptolysin O (Fig. 1b), allowed for single RNA molecule
sensitivity using conventional fluorescence microscopy techniques.
We identified the target RNA by the enhanced signal-to-background
ratio achieved through the binding of multiple MTRIPs per RNA
(two or three), via Watson-Crick base pairing3,5, or if using a single
MTRIP per RNA, through the natural localization of RNA (Fig. 1c).
This is analogous to the MS2-GFP binding systems, but uses native
target sequences and fewer binding sites.
To characterize probe sensitivity and delivery to the cytosol, we
immobilized probes targeting the genomic RNA of the wild-type
strain A2 of human respiratory syncytial virus (hRSV) on glass
surfaces and delivered them into non-infected A549 cells
using streptolysin O. After examining the images of the probe
mixtures on glass, the histograms of mean probe intensity and
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Figure 1 | Production and imaging of MTRIPs.
(a) Fluorophores (red) were conjugated to amino-
modified chimera oligonucleotides and bound to
streptavidin (blue). (b) Cells, permeabilized with
streptolysin O, allowed probe diffusion through
pores; this was followed by rapid binding of the
probes to targets, which was visualized after light
stimulation. (c) Single RNAs bound to multiple
probes were recognized by the enhanced signal-
to-background ratio. (d) Live-cell widefield,
deconvolved and merged images of a single
optical plane of Cy3B-labeled hRSV-targeted
probes in a noninfected A549 cell. Scale bars,
10 mm (2.5 mm in inset, which is a magnification
of the boxed region). (e) Intensity profile of
widefield and deconvolved images through yellow
line in the merge image in d.
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three-dimensional plots of the intensity of individual probes on the
glass surface, we concluded that the images detected single probes
and not aggregates (Supplementary Table 1 and Supplementary
Fig. 1 online). If the probes were aggregating, the histograms would
show non-unimodal behavior and mixtures of different color
probes would co-localize, which was not the case. In addition,
we delivered hRSV targeting probes labeled with Cy3B (GE
Healthcare) and Atto 647N (Atto-Tec GmbH) into non-infected
A549 cells. From a single optical plane within the live cell, we
observed individual probes to be homogenously distributed
in the cytoplasm (Fig. 1d,e) and did not observe localization or
accumulation of probes.
To test the ability to image single RNAs, we simultaneously
delivered two Cy3B-labeled MTRIPs designed to target two regions
of the human b-actin mRNA coding sequence (human b-actin
mRNA probes 1 and 2; Supplementary Table 1) and an Atto
647N–labeled ‘scrambled’ probe (no target in human genome)
(30 nM each) using streptolysin O into A549 cells. Twenty minutes
after delivery, we fixed the cells in 4% paraformaldehyde and
imaged them. We could image individual RNAs in both fixed
and live cells, but we fixed the cells for quantification because of the
dynamic nature of RNA granules. For b-actin, we observed indi-
vidual ‘unbound’ probes as well as localized granules with twice the
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Figure 2 | Imaging of single molecules of b-actin mRNA in an A549 cell. (a) b-actin mRNA and ‘scrambled’ probe imaged with a laser scanning confocal
microscope with all image planes represented. Merge images are also shown. (b) Intensity profiles along the yellow line in a. The black box highlights the large
numbers of b-actin mRNA individual granules at the cell periphery detected by the targeted probe, but not by the scrambled probe. (c) Single optical plane of
the same cell as in a resulting from widefield-deconvolution imaging. Scale bar, 5 mm. (d) Single optical plane of two living A549 cells (nucleus denoted with
dashed line) imaged at 1 Hz for 3 min and 5 Hz for 30 s, respectively. Inset, images of boxed regions, including traces of b-actin mRNA granule trajectories for
70 s (1 Hz) and 30 s (5 Hz). Starting points are denoted by arrows. Scale bars, 10 mm (3 mm in insets).
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Figure 3 | Transient interactions between
viral genomic RNA of hRSV and GFP–TIA-1.
(a) Fluorescence images of a live A549 cell imaged
24 h after infection and 48 h after transfection,
showing no stress granules. (b) Live-cell image of
a single optical plane of GFP–TIA-1 and Cy3B-
labeled hRSV-targeted MTRIPs (25 nM) in an A549
cell, 24 h after infection, 48 h after transfection
and 20 min after exposure to 1 mM sodium
arsenite. Arrowheads denote stress granules.
(c) Time-lapse images of stress granule (green)
collision, penetration and separation of a viral
RNA granule (red). (d) Images of the docking
of a stress and viral RNA granule, which occurred
for only 45 s before separation. All granule
interactions shown were imaged in the area
denoted by the box in b. All times are given in
seconds. Scale bars, 10 mm (a,b) and 1 mm (c,d).
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intensity (Fig. 2a–c). b-actin mRNA was prevalent in the peri-
nuclear region of the cell and also localized to the leading edges,
whereas the ‘scrambled’ probe produced perinuclear signals and
localized not at the cell periphery but in the cytoplasm, demon-
strating b-actin probe specificity. We quantified localization in an
intensity profile of the confocal image (Fig. 2b). From the lower-
noise, widefield-deconvolved image (Fig. 2c) we removed via
thresholding the average single-probe intensities, quantified from
probes on the glass surface, and counted the remaining granules
using Volocity (Improvision) software. Using this approach we
observed single b-actin mRNAs, containing approximately twice
the single probe intensity, in the cell (Fig. 2c) and detected a total of
1,455 granules. Granule mean fluorescence intensity (calculated
from the three-dimensional reconstruction) had a measured s.d. of
only 25% of the mean, reflecting the uniformity of the granules
when measured in three dimensions. The granule count was
consistent with previous quantifications (B1,500 in serum-stimu-
lated cells), using a similar analysis for b-actin mRNA in epithelial
cells6. In addition, we imaged b-actin mRNA granules in living cells
by time-lapse widefield fluorescence microscopy (Fig. 2d). We
collected images with 90-ms exposure times at both 1 Hz and
5 Hz for 3 min and 30 s, respectively (Supplementary Videos 1–3
online). This demonstrated the capacity to use this method in low-
and high-speed tracking experiments; similar particle trajectories
have been demonstrated for plasmid-derived mRNAs1. As an
additional control, we serum-starved A549 cells for 48 h and
counted the b-actin mRNA granules in cells fixed after live-cell
hybridization. A representative cell contained only 409 granules as
compared with 1,455 granules detected in a cell grown with serum
(data not shown), consistent with previous experiments6,7. We also
performed single-probe imaging of clustered RNAs and co-loca-
lized them with b-actin mRNA binding protein, ZBP1 (ref. 8) in
three dimensions (Supplementary Figs. 2 and 3 online), and
simultaneously imaged b-actin mRNA, actin-related protein 2
homolog mRNA and ZBP1 protein, in primary chicken embryonic
fibroblasts (Supplementary Fig. 4 online).
To test the utility of these probes for the study of RNA-protein
colocalization in live cells, we used Cy3B-labeled MTRIPs targeted
to the genomic RNA of hRSV in conjunction with a GFP–TIA-1
fusion protein in infected A549 cells, to evaluate the interaction
between the stress granule protein TIA-1 and hRSV viral RNA
when stress granules were induced by sodium arsenite treatment.
Previous findings demonstrated that paramyxovirus RNA, which
contains many possible TIA-1 or TIAR binding sites (uracil-rich
regions), likely interacts with stress granules9; this interaction
though, has not been characterized in living cells. In hRSV-infected
cells transfected with GFP–TIA-1, stress granules had not formed
24 h after infection as identified by the lack of aggregation of
GFP–TIA-1 in cells also containing viral RNA (Fig. 3a). MTRIPs
were specific and did not aggregate RNA (Supplementary Figs. 5–7
and Supplementary Results online).
To induce stress granules, we exposed the cells to 1.0 mM sodium
arsenite10 and observed substantial transient interactions between
stress and viral RNA granules (Fig. 3b–d). We observed a stress
granule moving into a viral RNA granule and residing within it for
over a minute before it was released (Fig. 3c and Supplementary
Videos 4 and 5 online). Another stress granule then appeared to
dock with a viral RNA granule (Fig. 3d and Supplementary Video
6 online), and appeared to be in contact for approximately 45 s.
Transient interactions between RNA granules on the same time
scales had been reported, supporting our observations, but pre-
viously engineered RNAs or proteins were imaged, in contrast to
the non-engineered RNAs imaged in this study11–13. We also
observed more stable interactions between GFP–TIA-1 and the
viral RNA (Supplementary Figs. 8 and 9 and Supplementary
Videos 7 and 8 online). Notably, the time-lapse results we present
here cannot be obtained using probes that require high (micro-
molar) probe concentrations and have lower sensitivity. The use of
less-sensitive probes would result in large RNA-protein exposure
time mismatches, resulting in the inability to track the interaction
of individual granules accurately.
Here we demonstrated that MTRIPs have single-molecule sensi-
tivity and can be used to target and follow native and non-
engineered RNA granules in living cells, in both a cell line and a
primary fibroblast using streptolysin O delivery; streptolysin O
delivery induced only minimal cell death (Supplementary Fig. 10
online) and did not change cellular morphology appreciably or
induce stress granules. Owing to their brightness at multiple
wavelengths, small size and ease of assembly, these probes should
be broadly applicable for studying single-molecule RNA-related
events in living cells.
METHODS
Methods and any associated references are available in the online
version of the paper at http://www.nature.com/naturemethods/.
Note: Supplementary information is available on the Nature Methods website.
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ONLINE METHODS
MTRIPs. The 2¢ O-methyl RNA-DNA chimera nucleic acid ligands
were synthesized by Biosearch Technologies, Inc. Each contains a
5¢ biotin modification and multiple dT-C6-NH2, modifications.
The streptavidin used for the core was purchased from Pierce.
Probes were assembled by first labeling the free amine groups on
the ligands with either Cy3B–NHS ester (GE Healthcare) or Atto
647N–NHS ester (Atto-Tec GmbH) using manufacturers’ proto-
cols. Free dye was removed using both Nanosep spin columns (Pall
Corp.) and illustra G-25 size-exclusion columns (GE Healthcare).
The purified ligands were resuspended in 1 phosphate-buffered
saline (PBS; pH 7.4) and mixed at a 10:1 molar ratio with
streptavidin for 1 h at room temperature (18–22 1C). Free ligands
were removed using 30 kDa Nanosep spin columns, and stored at
1 mM final concentration in 1 PBS at 4 1C. When multiple
probes were used, each probe was completely assembled and
filtered separately, and then mixed with equimolar concentrations
in streptolysin O and medium just before delivery into cells We
estimated the cost of MTRIPs, based on 30 nM delivery concen-
tration, to be $0.15 per well, for a 24-well plate.
Cells and virus. A549 lung carcinoma cells (American Type
Culture Collection CCL-185) were grown in DMEM (Sigma
Aldrich) with 10% fetal bovine serum (FBS; Hyclone) with
100 U ml–1 of penicillin and 100 mg ml–1 of streptomycin. Virus
used was the A2 strain of hRSV (American Type Culture Collec-
tion VR-1544) at a titer of 1  106 50% tissue culture infectious
dose (TCID50) ml
–1. The titer was evaluated by serial dilution and
immunostaining, 4 d after infection. Infection data shown (Fig. 3
and Supplementary Figs. 5–7) was at day 1 after infection and
with a multiplicity of infection of 5. All cells were infected at
greater than 80% confluence, by removing the media, washing
with 1 PBS (without Ca2+ and Mg2+) and then adding virus to
the cells for 30 min at 37 1C. After the 30-min incubation,
complete medium was added. For the motile epithelial cell
experiments, A549 cells were seeded at 5% confluence such that
there were a substantial number of cells without contacts with
other cells. For the motile fibroblast experiments, primary chicken
embryonic fibroblasts (Charles River Laboratories) were grown in
CEF growth medium (Charles River Laboratories), containing 5%
FBS and seeded at 5% confluence.
Probe delivery. MTRIPs were delivered into A549 and CEF cells
using a reversible permeabilization method with streptolysin O
(Sigma). Cells grown in complete medium were first washed with
1 PBS and then incubated with a mixture of 0.2 U ml–1 of
streptolysin O and probe (concentrations were noted in the main
text) in an appropriate amount of complete growth medium for
10 min at 37 1C. The mixture of streptolysin O, probe and
medium was then removed and replaced with fresh, complete
growth medium or Leibovitz’s L15 medium supplemented with
10% FBS. Live cells were imaged typically 20 min immediately
after delivery by epifluorescence microscopy. Using streptolysin O–
based delivery, probes were delivered into A549 and CEF cells with
100% efficiency.
Counting granules and statistical analysis of RNA granule
populations. For data shown in Figure 2 and Supplementary
Figure 7, granules were identified and counted using Improvi-
sion’s Volocity software in three dimensions using either confocal
images or from widefield fluorescence images, deconvolved using
an iterative deconvolution algorithm in Volocity. For data shown
in Figure 2, granules were counted using deconvolved data and
identified based on the s.d. of intensities; 4 s.d. above the mean
was used to locate the granules in all cases because it avoided the
detection of noise or objects substantially smaller than the point
spread function. Because of this, no limit on minimum granule
size was necessary when counting granules. In general, the cells
deconvolved using the three-dimensional interative algorithm in
Volocity lacked considerable noise due to filtering in the algo-
rithm. Notably, the s.d. in mean granule intensity for the granules
in Figure 2c and in the serum-starved cell (data not shown) were
only 25% and 21%, respectively, reflecting the uniformity of the
granules when measured in three dimensions. For data shown in
Supplementary Figure 7, the number of granules was detected
using the same criteria using confocal data from tetravalent
MTRIPs and a monovalent ligand (ligands not connected by
streptavidin) in approximately 30 cells each. The results were
compared using the Wilcoxon-Mann-Whitney (WMW) test to
determine whether the two samples came from the same popula-
tion. WMW is a nonparametric test is traditionally used to test
equality of locations in two populations, but in its general form
this test is about the equality of distributions14. The null hypoth-
esis states that the distributions of the two samples coincide and
the alternative is that the distributions differ. The P value for
WMW test when comparing the number of granules detected by
each probe was 0.8737, which means that the evidence for the null
hypothesis is decisive; consequently, the distributions were
assumed to be the same.
Plasmids and transfections. The pSRa-GFP-HA-TIA-1 plasmid15
was used to image stress granules in living cells. A549 cells plated
in penicillin- and streptomycin-free medium were transfected
using Fugene HD (Roche) at a ratio of Fugene HD to DNA of
2.5 ml mg–1.
Time-lapse fluorescence microscopy. Live-cell video microscopy
was performed using cells grown in Bioptechs T4 plates with an
objective heater. The cells were imaged in Leibovitz’s L15 medium
supplemented with 10% FBS. Images were taken with a Zeiss
Axiovert 200M microscope, with an 63, numerical aperture
(NA) ¼ 1.4 Plan-Apochromat objective and Hamamatsu
ORCA-ER AG camera, using Chroma 49002 ET-GFP and 49004
ET-Cy3 filter sets, controlled by Volocity software. For b-actin
mRNA granule dynamics, images were taken either at 1 or 5 Hz
with 90-ms exposures for 3 min and 30 s, respectively. For the
stress granule-RNA experiments, images of GFP–TIA-1 and the
Cy3B-labeled MTRIPS were taken at 0.2 Hz (every 5 s), with
exposure times of 71 and 41 ms, respectively, for up to 8 min.
Stress granule-RNA time-lapse microscopy. A549 cells, trans-
fected with the above plasmid for 24 h were then infected with
hRSV as above. Twenty-four hours after infection, the MTRIPs
were delivered at 25 nM final concentration, and the cells exposed
to 1.0 mM sodium arsenite for 30 min15. During the 30-min
incubation, the cells were observed periodically using epifluores-
cence microscopy. After 15 min of exposure, stress granules
(marked by GFP–TIA-1 aggregates) were observed; an imaging
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plane containing both RNA granules and stress granules was
chosen and time-lapse microscopy was initiated. Out-of-focus
light was removed using Volocity’s 2D deconvolution algorithm.
Starvation assay. A549 cells were serum-starved in DMEM with
100 U ml–1 of penicillin and 100 mg ml–1 of streptomycin for 48 h.
MTRIPS (human b-actin mRNA probes 1 and 2) were delivered
with streptolysin O. Twenty minutes after delivery, the cells were
fixed in 4% paraformaldehyde and stained with DAPI. The
granules in a particular cell were then counted using the method
described above.
Immunostaining. Twenty to thirty minutes after probe delivery,
cells were fixed in 4% paraformaldehyde in 1 PBS for 10 min at
room temperature. After fixation, cells were permeabilized using
0.2% Triton-X 100 for 5 min at room temperature, washed in 1
PBS, blocked for 30 min in 5% BSA (ultrapure), washed in 1
PBS, incubated with primary antibody for 30 min at 37 1C, washed
3 with 1 PBS, incubated in secondary antibody labeled with
Alexa 488 for 30 min at 37 1C, washed 3 with 1 PBS, labeled
with DAPI for 5 min (in the RSV experiments) and then mounted
in PVA with Dabco. The monoclonal antibody for the hRSV
nucleocapsid protein was from Abcam, and the polyclonal Ab for
ZBP1 from the Bassell laboratory. Polyclonal ZBP1 antibodies were
produced by immunizing guinea pigs with a synthetic peptide
corresponding to residues 162–175 (CGPENGRRGGFGSRG; the
first Cys is for conjugation) within a hinge region between two
RRM and four KH domains of human ZBP1. This region is
conserved completely among mouse, rat and human ZBP1
proteins, but not Imp2 or Imp3. The ZBP1 antibody does not
recognize mouse Imp2 or Imp3 by western blotting (data
not shown). F-actin was stained using Alexa 488–labeled
phalloidin (Invitrogen).
Fluorescence imaging. Immobilized Cy3B and Atto 647N probes
on the glass surface were imaged using a Zeiss Axiovert 200M
microscope with an 63, NA ¼ 1.4 Plan-Apochromat objective,
using Chroma 49004 ET-Cy3 and 49006 ET-Cy5 filter sets,
with 500-ms exposures. An EXFO excite 120 light source with a
ND (neutral density) ¼ 0.4 (40% transmission) was used for
fluorescence excitation, and a Hamamatsu ORCA-ER AG for
taking digital images. Live-cell images of single probes within
A549 cells were taken with 350 ms exposures under the same
illumination conditions. Z-dimension stacks were taken in both
cases, in 200-nm steps, and deconvolved using Volocity iterative
deconvolution algorithm. Cells used in the human b-actin mRNA-
scrambled probe experiments were fixed after live-cell hybridiza-
tion and imaged similarly to the immobilized probes, but with
200-ms exposures and deconvolved in Volocity. Time-lapse live
cell images were taken as discussed above, and were processed with
Volocity’s 2D or fast deconvolution algorithm. In the stress granule
control experiments, live cell images were taken similarly to the
single probe images but with 50-ms exposures. hRSV after-
delivery, fixed-cell control experiments were imaged with a
ZeissLSM 510 Meta using an 63, NA ¼ 1.4, Plan-Apochromat
objective. All images were taken using multi-track scanning for
each fluorophore to prevent bleed-through. Z-dimension stacks
were taken in 0.5-mm increments; the 543 nm laser (Cy3B probe)
was set at 25% power, the 488 nm laser (for N protein immuno-
staining) was set at 37%, and the pinholes were set to an airy unit
of 1 (equal to airy disk). b-actin mRNA, actin-related protein 2
homolog mRNA and ZBP1, in the chicken embryonic fibroblasts,
were imaged under similar conditions to the human b-actin
mRNA experiments.
Image analysis. Images were analyzed using Volocity software and
NIH ImageJ. Volocity was used to deconvolve the widefield images
(2D and full-iterative), reconstruct the images in three dimensions,
identify individual probes based on intensity and measure the
mean intensity within granules of all sizes. It was also used to
perform the three-dimensional co-localization calculations of
Manders coefficient. The Color Profiler tool in ImageJ was
used to obtain profile data for the intensity plots from the
merged images.
Live-dead assay. To asses the effects of streptolysin O, and the
Invitrogen L-3224 Live/Dead Viability/Cytotoxicity kit for mam-
malian cells was used as per the manufacturers instructions. The
images were taken on a Zeiss 200M widefield epi-fluorescence
microscope with an LD Plan-Neofluar 20, NA ¼ 0.4 objective,
Hamamatsu ORCA ER-AG camera, and appropriate filter sets
described above.
14. Conover, W.J. Practical Nonparametric Statistics 3rd edn. (Wiley, New York, 1999).
15. Kedersha, N. et al. J. Cell Biol. 151, 1257–1268 (2000).
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Respiratory Syncytial Virus Induces Host RNA Stress Granules
To Facilitate Viral Replication
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Mammalian cell cytoplasmic RNA stress granules are induced during various conditions of stress and are
strongly associated with regulation of host mRNA translation. Several viruses induce stress granules during
the course of infection, but the exact function of these structures during virus replication is not well under-
stood. In this study, we showed that respiratory syncytial virus (RSV) induced host stress granules in epithelial
cells during the course of infection. We also showed that stress granules are distinct from cytoplasmic viral
inclusion bodies and that the RNA binding protein HuR, normally found in stress granules, also localized to
viral inclusion bodies during infection. Interestingly, we demonstrated that infected cells containing stress
granules also contained more RSV protein than infected cells that did not form inclusion bodies. To address
the role of stress granule formation in RSV infection, we generated a stable epithelial cell line with reduced
expression of the Ras-GAP SH3 domain-binding protein (G3BP) that displayed an inhibited stress granule
response. Surprisingly, RSV replication was impaired in these cells compared to its replication in cells with
intact G3BP expression. In contrast, knockdown of HuR by RNA interference did not affect stress granule
formation or RSV replication. Finally, using RNA probes specific for RSV genomic RNA, we found that viral
RNA predominantly localized to viral inclusion bodies but a small percentage also interacted with stress
granules during infection. These results suggest that RSV induces a host stress granule response and prefer-
entially replicates in host cells that have committed to a stress response.
Respiratory syncytial virus (RSV) is a leading cause of seri-
ous viral lower respiratory tract illness in infants and the el-
derly worldwide. The virus is a member of the Paramyxoviridae
family, and the genome consists of a single-stranded, negative-
sense RNA molecule that encodes 11 proteins. The ribonucleo-
protein complex necessary for transcription and replication
includes the nucleoprotein (N), the phosphoprotein (P), and
the large polymerase protein (L). M2-1 and M2-2 are accessory
proteins that are involved in transcription and replication, re-
spectively (7). The fusion (F) protein, attachment protein (G),
and small hydrophobic (SH) protein are found on the surface
of infectious virions, while the matrix (M) protein locates in-
side the virion particle. Two nonstructural proteins (NS1 and
NS2) are expressed in the cytoplasm of infected cells and
appear to act as interferon antagonists during infection (36).
The mechanisms by which the virus replicates and assembles in
infected epithelial cells are incompletely understood.
A hallmark feature of RSV infection in epithelial cells is the
formation of discrete collections of viral replication proteins
that have been termed viral inclusion bodies (28). These cyto-
plasmic structures increase in size during the course of infec-
tion and have been shown to contain the N, P, M2-1, L, and M
proteins (3, 9, 21). It is thought that N and P are the minimal
requirements for inclusion body formation, since the expres-
sion of both of these proteins in the absence of virus infection
induces the formation of inclusion bodies similar to those ob-
served during infection (10). The host proteins Hsp70 and
actin associate with RSV inclusion bodies (1), but a functional
role for either of these proteins in inclusion bodies is unknown.
Although a function has not been defined experimentally for
inclusion bodies, it has been proposed that these structures
may represent sites of replication and/or transcription for the
virus (32).
Stress granules are host RNA cytoplasmic granules formed
in cells in response to multiple types of environmental stress
(14). The best-studied pathway for stress granule formation
involves phosphorylation of the translation initiation factor
eIF2, leading to the accumulation of stalled translation
preinitiation complexes (19). RNA transcripts are bound by
mRNA binding proteins, including TIA-1, Ras-GAP SH3 do-
main-binding protein (G3BP), and HuR. Several translation
factors, such as eIF4E and eIF3, are recruited to stress gran-
ules, resulting in protein-RNA complexes that form the con-
tents of the granules (14). Stress granules can also be induced
by an alternate mechanism that is independent of eIF2 phos-
phorylation via inactivation of the translation factors eIF4A or
eIF4G (5, 25).
Many viruses are known to modulate host translation in
order to facilitate viral protein production. In recent years,
several viruses have been studied to monitor their effect on the
host stress response. Viruses that are known to induce host
stress granules include the paramyxovirus Sendai virus, the
coronavirus mouse hepatitis virus, the alphavirus Semliki For-
est virus, reovirus, and poliovirus (12, 24, 30, 34, 39). Although
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both poliovirus and Semliki Forest virus induce stress granules
early after infection, both viruses appear to functionally inhibit
stress granule formation at later time points. In addition, West
Nile virus prevents stress granule formation throughout infec-
tion (6). While it is reasonable to think that stress granules may
play a role in infection for these viruses, the specific role or
function of stress granules during infection has not been well
defined.
Stress granule proteins also have been shown to interact
directly with viral processes. Sindbis virus and vaccinia virus
recruit the stress granule protein G3BP to viral structures (4,
13), while West Nile virus interacts with the host stress granule
proteins TIA-1 and TIAR (6). Sendai virus trailer RNAs have
been shown to bind TIAR (12), and the poliovirus 3C protein-
ase has been shown to cleave G3BP (39). HuR has been shown
to associate with regions of hepatitis C virus (HCV) RNA and
the reverse transcriptase protein of human immunodeficiency
virus (31, 35).
In the present study, we sought to determine whether the
pneumovirus RSV initiates a stress response. Our results dem-
onstrate that RSV induces a robust stress response that con-
tinues throughout the course of infection, indicating that RSV
may specifically initiate and maintain the stress response. In-
terestingly, we show that cells that have formed stress granules
contain more RSV protein than cells without stress granules.
Our data show that, while RSV inclusion bodies are distinct
from stress granules, the stress granule marker HuR appears to
be a shared component between both structures. In addition,
we created a stable cell line deficient for the stress granule
assembly protein G3BP. RSV replication in these cells was
diminished, offering further evidence that stress granule for-
mation enhances RSV replication. Finally, we show that RSV
genomic RNA is strongly associated with RSV inclusion bodies
while only a transient interaction occurs with stress granules.
This evidence suggests that RSV inclusion bodies and not host
stress granules are the active sites of viral replication.
MATERIALS AND METHODS
Cells. HEp-2 cells (ATCC CCL-23) were maintained in Opti-MEM I medium
(Invitrogen) containing 5% (vol/vol) fetal calf serum, 1% (vol/vol) L-glutamine,
2.5 g/ml amphotericin B, and 50 g/ml gentamicin. MA104 cells (ATCC CRL
2738.1), which were used to prepare rotavirus, and RGD3 and U2OS cells
(kindly provided by Paul Anderson, Brigham and Women’s Hospital) were
maintained in Dulbecco’s modified Eagle’s medium (DMEM) containing 5%
(vol/vol) fetal calf serum, 1% (vol/vol) sodium pyruvate, 1% (vol/vol) L-glu-
tamine, 1% (vol/vol) nonessential amino acids, 2.5 g/ml amphotericin B, and 50
g/ml gentamicin.
Viruses. A suspension of RSV wild-type strain A2 prepared in HEp-2 cells
(1  106 PFU/ml) was used to infect HEp-2 cell monolayer cultures. Infectious
virus was adsorbed to the cells for 1 h in a 37°C incubator in 5% CO2. Following
adsorption, the inoculum was removed and fresh medium added. The cells were
then incubated at 37°C in 5% CO2 for the duration of the infection period.
UV-inactivated virus was prepared from the same virus stock by irradiation in a
UV cross-linker for 15 min. Rhesus rotavirus was a kind gift from Susana Lopez.
Fixation and immunostaining. Cells were fixed with 3.7% (wt/vol) parafor-
maldehyde in phosphate-buffered saline (PBS) for 10 min at room temperature.
Cells were permeabilized with 0.2% (wt/vol) Triton X-100 and 3.7% paraform-
aldehyde in PBS for 10 min at room temperature. Following fixation, cells were
blocked in 5% (wt/vol) bovine serum albumin (BSA) in PBS for 1 h, followed by
the addition of the primary antibody for 1 h. Cells were then washed three times
in PBS, and species-specific IgG Alexa Fluor (Molecular Probes) was added at a
dilution of 1:1,000 in blocking solution to detect primary antibodies. Cells were
washed 3 times in PBS and fixed on glass slides using a Prolong antifade kit
(Molecular Probes). Images were obtained on a Zeiss inverted LSM510 confocal
microscope using a 40 Plan-Neofluar oil objective lens. Polyclonal anti-G3BP
(ab37906) antibody was obtained from Abcam and used for immunostaining. The
following antibodies were obtained from Santa Cruz for immunostaining: poly-
clonal anti-TIA-1 (sc-1751), polyclonal anti-HuR (sc-20694), and polyclonal anti-
eIF3 (sc-16377). Anti-RSV P protein (clone 3_5) and anti-RSV N protein
(clone B130) monoclonal antibodies were a kind gift of Earling Norrby and Ewa
Bjorling. An anti-RSV F protein humanized mouse monoclonal antibody (palivi-
zumab; MedImmune) was obtained from the Vanderbilt Pharmacy. Imaging of
the RNA with G3BP and RSV N protein was performed using a 63/1.4 nu-
merical aperture Plan-Apochromat objective using a Zeiss LSM 510 confocal
microscope. For images where three-dimensional z-stacks were obtained, we
collapsed the series of fields into an extended view using Volocity imaging
software.
RT-PCR. HEp-2 cells were grown on 48-well plates and infected with RSV for
the times indicated below. RNA was extracted using an RNeasy mini kit (Qia-
gen). Reverse transcriptase PCR (RT-PCR) was performed using a OneStep
RT-PCR kit (Qiagen) and primer-probe combinations for RSV F, rotavirus VP3,
or human glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The normal-
ized cycle threshold (CT) was calculated for each time point using the following
formula: CT  RSV F CT  GAPDH CT. The change in normalized CT over
time (CT) was calculated for each condition using the CT of wild-type cells
2 h postinfection (p.i.) as the initial point of reference for the relative amount of
viral RNA: CT [CT at x h p.i. shRNA] [CT in wild-type cells 2 h p.i.],
where x equals each specific time point.
shRNA reagents. A stable cell line exhibiting knockdown of HuR expression
was generated using a set of three SMARTvector lentiviral small hairpin RNA
(shRNA) particles (Dharmacon), along with cells treated with nontargeting
shRNA particles. HEp-2 cells were plated into 48-well plates at approximately
50% confluence and transduced with the lentiviral particles according to the
manufacturer’s protocol. A panel of stable cell lines exhibiting knockdown of
G3BP expression was generated using Mission shRNA lentiviral transduction
particles (Sigma). HEp-2 cells were plated onto 6-well plates and transduced with
lentiviral particles according to the manufacturer’s protocol. For selection of
each target, cells containing integrated lentivirus sequences were selected using
puromycin (5 g/ml) diluted in medium. Medium containing puromycin was
replaced every 3 days until resistant colonies were observed. Puromycin-resistant
colonies were isolated using cloning cylinders (Sigma) and tested for target
protein expression.
Western blotting. HEp-2 cells were grown on 6-well plates and harvested for
protein. Cell lysates were obtained using lysis buffer (50 mM Tris-HCl, 150 mM
NaCl, 1% Triton X-100, pH 8.0) containing 0.5% (vol/vol) protease inhibitor
cocktail (Sigma) and 1.0% (vol/vol) phosphatase inhibitors (Sigma). The lysates
were separated on 4-to-12% NuPAGE bis-Tris gels (Invitrogen) and transferred
to nitrocellulose membranes using an iBlot dry blotting system (Invitrogen). The
membranes were blocked for 1 h using Odyssey blocking buffer (Li-Cor) diluted
1:1 in PBS. Primary antibodies were diluted in blocking buffer and incubated
overnight at 4°C. The membranes were then washed four times in Tris-buffered
saline plus 0.2% Tween (TBST) for 5 min each. Li-Cor IRDye 680CW or IRDye
800CW secondary antibodies were diluted 1:5,000 in blocking buffer and added
to each membrane for 1 h. The membranes were washed four times in TBST.
Bands were imaged and quantitated using an Odyssey infrared imaging system.
G3BP protein was detected using a monoclonal antibody from BD Biosciences
(611127). GAPDH was detected using a monoclonal antibody from Millipore
(MAB374). HuR was detected using a monoclonal antibody from Santa Cruz
Biotechnology (sc-5261).
RNA probe and live cell delivery. Single-RNA-sensitive probes (33) designed
to target the gene start-intergenic region of the genomic RNA of human RSV
were delivered at 30 nM via reversible permeabilization with streptolysin O into
separate sets of infected or mock-infected HEp-2 cells at 1, 6, 12, 18, and 24 h p.i.
Delivery took approximately 10 min, and 15 min after delivery, the cells were
fixed with 3.7% (wt/vol) paraformaldehyde in PBS for 10 min at room temper-
ature. The cells could then be immunostained for G3BP and the RSV N protein
as discussed above.
Quantification of imaging. To determine quantitative features of stress gran-
ule induction by RSV, HEp-2 cells were plated onto coverslips placed in wells of
a 24-well plate. Cells were grown to approximately 75% confluence and were
infected with RSV for 0, 6, 12, 16, 20, or 24 h (multiplicity of infection [MOI] of
1). Cells were fixed as described above. Cells were stained with anti-G3BP
antibody (BD Transduction Laboratories) diluted 1:1,000 in blocking solution,
the anti-RSV F protein antibody palivizumab (MedImmune) diluted 1:10,000 in
blocking solution, and the nuclear stain To-Pro-3 iodide (Invitrogen) diluted
1:1,000 in blocking solution for 1 h. Twenty high-powered fields (HPFs) were
obtained for each time point. Images were examined using Volocity imaging
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software (version 5.1; Improvision). The total number of cells in each HPF was
quantified by counting the number of nuclei. We also quantified the number of
infected cells by staining for the presence of RSV F protein, the number of cells
containing stress granules by staining for the presence of G3BP protein, and the
number of infected cells that also contained stress granules per HPF. To calcu-
late the stress granule size in wild-type or G3BP-deficient cells, cells were plated
onto coverslips placed in wells of a 24-well plate. The cells were then treated with
0.5 mM arsenite for 15 min. The cells were fixed and stained for G3BP (1:500)
and TIA-1 (1:250). Images for 10 HPFs were obtained for each cell line. We then
used Volocity imaging software to determine the percentage of cells with stress
granules per HPF and the size of each stress granule for those cells containing
stress granules. To determine inclusion body number and volume, HEp-2 cells
were placed on coverslips in 24-well plates. Cells were infected with RSV for 24 h
(MOI  1.0) and fixed. Cells were stained for inclusion bodies using anti-RSV P
protein antibody and for stress granules using anti-G3BP antibody. At least 10
cells containing or not containing stress granules were analyzed for inclusion
bodies. Volocity imaging software was used to determine the number and volume
of individual inclusion bodies per cell. Volocity was also used to quantify the
colocalization of the viral genomic RNA with inclusion bodies (marked by the
RSV N protein) or with stress granules, in addition to the colocalization of
inclusion bodies with stress granules. Manders overlap coefficients were calcu-
lated using voxels generated from three-dimensional reconstructions.
RESULTS
RSV infection induces stress granule formation. We first
tested whether RSV infection of epithelial cells induced stress
granules. HEp-2 cell monolayer cultures were inoculated with
RSV wild-type strain A2 at an MOI of 1 and incubated in
liquid medium for 24 h. We then fixed the cells and immuno-
stained them for the stress granule proteins G3BP, eIF3, or
TIA-1. The results in Fig. 1A (first column) show that each of
these markers frequently relocalized into dense cytoplasmic
foci that are characteristic of stress granules. We noted that the
host stress granules appeared similar in size, shape, and loca-
tion to previously described viral inclusion bodies that form
during RSV infection. To investigate whether the granules
containing stress granule-associated proteins were viral inclu-
sion bodies, we costained infected cells with antibodies to
stress granule markers and one of the viral proteins found in
inclusion bodies (RSV P protein) (Fig. 1A, middle column).
The results indicate that viral inclusion bodies are spatially
separated from stress granules and represent distinct struc-
tures in the cytoplasm.
We next performed a time course of infection to determine
the kinetics of stress granule formation in RSV-infected cells.
We inoculated cells with RSV (MOI  1) and then incubated
them for various times (0 to 24 h). We fixed and immuno-
stained cells for RSV F protein and the stress granule protein
marker G3BP. After 12 h, stress granules formed, and the
number of infected cells containing stress granules increased
incrementally throughout the 24-h period of observation (Fig.
1B). We did not observe stress granules in mock-infected cells
over the time course. In addition, in the cultures in which RSV
was added, we did not observe stress granules in cells that did
not stain for RSV protein (data not shown). These results
demonstrated that RSV induces a potent stress granule re-
sponse beginning at about 12 h after inoculation and continu-
ing throughout the viral life cycle. In order to verify that RSV
replication is necessary for stress granule formation, we mock
inoculated cells, inoculated cells with replication-competent
RSV (MOI  1.0), or inoculated cells with an equivalent
volume of UV-inactivated RSV for 48 h and then fixed and
immunostained them for RSV F and G3BP. RSV infection
once again induced robust stress granule formation (Fig. 2,
bottom row), while we did not observe stress granules in mock-
inoculated or UV-inactivated RSV-inoculated samples (Fig. 2,
top and middle rows). These results confirmed that RSV rep-
lication and not simply the presence of RSV protein is required
for stress granule formation.
We next compared RSV protein levels between cells with
and without stress granules. HEp-2 cells were inoculated with
RSV (MOI  1.0) for 24 h and then fixed and immunostained
for RSV P and G3BP. We used RSV inclusion body size and
number as a measure to compare the amounts of viral protein
present in cells. Interestingly, the results indicated that in-
fected cells that have formed stress granules contain more
inclusion bodies than cells that have not formed stress granules
(Fig. 3A). In addition, individual inclusion bodies were larger
in cells that had formed stress granules (Fig. 3B) and the total
amount of protein contained in inclusion bodies was greater
(Fig. 3C). Although quantification of the size and number of
inclusion bodies in infected cells in the cultures clearly showed
larger and more inclusion bodies in cells with stress granules,
we also did observe some individual cells without stress gran-
ules that contained large amounts of RSV protein (for exam-
ple, two cells with high N expression in Fig. 7, at 12 h postin-
fection). These data suggested that stress granules enhance
viral protein production and inclusion body formation but are
not absolutely required for these viral processes.
Inhibition of host stress granule formation reduces RSV
replication. To investigate whether stress granule formation is
beneficial to the virus or the host, we inoculated mouse embryo
fibroblast (MEF) lines derived from TIA-1- or TIAR-deficient
mice (kindly provided by Paul Anderson); however, RSV did
not establish a productive infection in these cells (data not
shown). It is well established that human RSV strains do not
infect murine cells efficiently. Next, we created human cell
lines deficient for stress granule formation by transducing
HEp-2 cells with lentiviral shRNA transduction particles to
induce stable knockdown of G3BP expression. When analyzed
by Western blotting, G3BP was not detected in the knockdown
cells (Fig. 4A). However, when these cells were compared with
wild-type cells by immunofluorescence, we could still observe a
small amount of G3BP in fixed and permeabilized knockdown
cells. The G3BP-deficient cells expressed normal amounts of
other stress granule proteins, such as TIA-1 (Fig. 4B). G3BP-
deficient cells were treated with 0.5 mM arsenite for 15 min to
determine if they were capable of forming stress granules.
Stress granules were detected using anti-TIA-1 antibodies (Fig.
4C). We compared the percentages of cells with stress granules
per high-powered field. In G3BP-deficient cells, approximately
75% fewer cells per HPF formed stress granules. We also
examined individual G3BP knockdown cells that did form
stress granules and noted that there was also a slight decrease
in stress granule size compared to those in wild-type HEp-2
cells. These results indicated that G3BP-deficient cells are im-
paired for stress granule formation.
We next determined whether RSV replication was altered in
the G3BP-deficient cell line. Wild-type or G3BP-deficient cells
were infected with RSV (MOI  1) for 1, 2, or 4 days. Cell-
associated and supernatant virus were collected separately, and
viral titers were determined using plaque assays. The G3BP-
deficient cells consistently demonstrated a 10-fold reduction in
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viral titer when comparing supernatant or cell-associated virus
with the titers collected from wild-type cells (Fig. 5A). In
addition, RSV infection was associated with the death of most
wild-type HEp-2 cells after 2 days, while in contrast, the G3BP-
deficient cells consistently remained viable for 4 days after
infection. We next sought to determine if the reduction of
G3BP expression and stress granule formation affected the
efficiency of replication of viral RNA. We infected wild-type or
G3BP-deficient cells for 0, 2, 12, 24, or 48 h and then harvested
total RNA from cell lysates. We performed reverse transcrip-
tase PCR and normalized the RNA levels to that of host
GAPDH and compared them with the levels found at 2 h
FIG. 1. Stress granules (SGs) are induced during RSV infection. (A) HEp-2 cells were infected with RSV (MOI  1.0) for 24 h, fixed, and
processed for immunofluorescence. Anti-G3BP, anti-eIF3, and anti-TIA-1 were used as stress granule markers and appear red in the merged
image. Anti-RSV P was used as the viral inclusion body marker and appears green in the merged image. The collapsed z-sections are shown for
each image. (B) HEp-2 cells were infected with RSV (MOI  1.0) for the indicated times. The percentages of infected cells and cells containing
stress granules per HPF were quantified as described in Materials and Methods. Error bars show standard deviations.
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postinfection in the wild-type HEp-2 cells. We observed a
decrease in RSV RNA in the G3BP-deficient cell line at each
time point tested after infection (Fig. 5B). Interestingly, when
these cells were infected with rhesus rotavirus, a virus that does
not induce stress granule formation (27), the replication of
rotavirus was unaffected. These data indicate that stress gran-
ule formation may play an important role in the RSV life cycle
even at very early time points after infection.
We also determined the effects of G3BP overexpression on
RSV replication using RGD3 cells, a U2OS osteosarcoma cell
line selected to express green fluorescent protein-G3BP. We
inoculated RGD3 or parental U2OS cells with RSV (MOI 
1.0) and harvested cell-associated virus for plaque assays at
time points spanning 0 to 4 days after inoculation. RSV repli-
cation remained largely unaltered in cells overexpressing
G3BP (Fig. 5C). Interestingly, although G3BP levels are higher
in RGD3 cells, stress granule formation is largely unaltered
(18). These data indicated that the presence of artificially el-
evated levels of G3BP do not enhance replication.
The stress granule marker HuR is recruited to RSV inclu-
sion bodies. We examined other markers of stress granules and
found a nonclassical feature involving the mRNA binding
stress granule protein HuR. In cells infected with RSV, HuR
was recruited to stress granules during infection but the pro-
tein was also largely associated with structures that were not
marked by other stress granule proteins. When cells were in-
fected (MOI 1) and costained for G3BP and viral proteins in
RSV inclusion bodies, we noted that HuR was present both in
host stress granules and in RSV inclusion bodies (Fig. 6A).
Thus, HuR protein is a shared component of the two struc-
tures. Using RNA interference, we sought to determine the
effect of decreased HuR expression on RSV replication.
shRNA knockdown of HuR resulted in an approximately 70%
reduction of HuR expression when compared by Western blot-
ting to its expression in wild-type cells or cells transduced with
a nontargeting shRNA (Fig. 6B). In contrast to G3BP knock-
down, stress granule formation was not altered by HuR reduc-
tion when cells were treated with sodium arsenite (data not
shown). To test whether HuR plays a role in RSV infection, we
infected wild-type HEp-2- or HuR-deficient cells with RSV
(MOI  0.1) for 1, 2, 3, or 4 days. Supernatant and cell-
associated virus were collected separately at each time point,
and viral titers were determined by plaque assay. As shown by
the results in Fig. 6D, we did not observe a significant change
FIG. 2. RSV-induced stress granule formation is dependent on vi-
rus replication. HEp-2 cells mock infected (top row), inoculated with
replication-competent RSV (MOI  1.0), or inoculated with UV-
inactivated RSV for 48 h were fixed and processed for immunofluo-
rescence. Anti-G3BP was used as a marker for stress granules and
appears red in the merged image. Anti-RSV F was used as a marker
for viral infection and appears green in the merged image. The col-
lapsed z-sections are shown for each image.
FIG. 3. RSV protein levels are higher in cells with stress granules.
HEp-2 cells were infected with RSV (MOI  1.0) for 24 h. At least 10
infected cells containing or not containing stress granules were ana-
lyzed. (A) The total average number of inclusion bodies (IBs) per cell
was determined as described in Materials and Methods for cells con-
taining stress granules (	SGs) or not containing stress granules (No
SGs). (B) The average volumes (m3) of individual inclusion bodies
were determined for cells containing or not containing stress granules.
(C) The volumes of all individual inclusion bodies in single cells con-
taining or not containing stress granules were totaled on a per cell basis
to determine average total inclusion body volume per cell. Error bars
show standard deviations.
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FIG. 4. Decreased levels of G3BP inhibit stress granule formation. (A) Wild-type or representative G3BP-deficient HEp-2 cells were analyzed
for G3BP expression via Western blotting. (B) Wild-type or G3BP-deficient HEp-2 cells not treated with arsenite were analyzed for G3BP (green
in merged image) and TIA-1 (red in merged image) expression using indirect immunofluorescence. (C) Wild-type or G3BP-deficient HEp-2 cells
were treated with arsenite, fixed, and processed for immunofluorescence. Stress granule proteins were stained using anti-G3BP (green in merged
image) and TIA-1 (red in merged image) antibodies. (D) Each cell type was examined for the percentage of cells containing stress granules per
HPF and the size of stress granules per cell using TIA-1 as a marker for stress granules, as described in Materials and Methods. Error bars show
standard deviations. KD, knockdown.
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in viral titer for supernatant or cell-associated virus during
infection in HuR-deficient cells. In addition, we monitored for
any changes in RSV RNA levels. Wild-type or HuR-deficient
cells were infected (MOI 0.1) for the times stated above, and
RNA was harvested. We again performed quantitative RNA
studies. As shown by the results in Fig. 6C, we did not find
significant differences in RSV RNA levels when HuR expres-
sion was reduced. These data, combined with our viral titer
results, indicate that the wild-type level of HuR expression is
not essential for viral replication even though a significant
amount of HuR is recruited to inclusion bodies.
RSV genomic RNA is partially localized to stress granules.
Previous reports using fluorescent molecular beacons specific
for RSV genomic RNA suggested that RSV RNA could be
found in RSV inclusion bodies during infection (32). In addi-
tion, more recent studies have shown that RSV RNA tran-
siently interacts with arsenite-induced stress granules as well
(33). Using a probe specific for RSV genomic RNA, we sought
to determine whether RSV RNA could be found in RSV-
induced stress granules, as well as RSV inclusion bodies.
HEp-2 cells were infected with RSV (MOI  1) for 1, 6, 12,
and 24 h. After infection, cells were reversibly permeabilized
with streptolysin O and incubated with fluorescently labeled
RNA probes. Cells were then fixed with paraformaldehyde and
stained with a monoclonal RSV N antibody to identify inclu-
sion bodies and a monoclonal anti-G3BP antibody to identify
stress granules (Fig. 7). Using confocal microscopy, we then
examined the localization of viral RNA at each time point. We
observed colocalization between RSV inclusion bodies and
viral RNA at all time points, 1, 12, and 24 h after infection, as
FIG. 5. RSV replication is inhibited in G3BP-deficient cells. (A) Wild-type (WT) or representative G3BP-deficient cells were infected with
RSV (MOI  1.0) for indicated times. Cell-associated or supernatant virus was collected at each time point. Viral titer for each sample was
determined by plaque assay. (B) Wild-type or G3BP-deficient cells were infected with RSV or rotavirus for indicated times. Viral RNA was
collected and assayed for fold change of RNA during infection. (C) Wild-type or G3BP-overexpressing cells derived from U2OS cells (RGD3) were
infected with RSV (MOI  1.0) for indicated times. Cell-associated virus was collected at each time point, and viral titer for each sample was
determined by plaque assay. Error bars show standard deviations.
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shown in Fig. 7. Using Volocity imaging software, we deter-
mined the average Manders overlap coefficients for inclusion
bodies with viral RNA, inclusion bodies with stress granules,
and viral RNA with stress granules, utilizing three fields of
approximately 35 cells (Table 1). For viral RNA and inclusion
bodies, the Manders overlap coefficients were 0.87, 0.96, and
0.91 (87, 96, and 91% overlap) for 1, 12, and 24 h after infec-
tion, respectively. For the inclusion bodies with stress granules,
the average Manders overlap coefficients were 0.0, 0.016, and
0.034 (0 [no stress granules], 1.6, and 3.4% overlap), likely
representing a transient interaction. For the viral RNA with
stress granules, the average Manders overlap coefficients were
0.0, 0.022, and 0.045 (0 [no stress granules], 2.2, and 4.5%
overlap), also likely representing a transient interaction. In
addition, we show the overlapping intensity profiles of the viral
RNA, inclusion bodies, and stress granules (as visualized in
intensity profiles in the fifth column of Fig. 7) to demonstrate
the amount of colocalization between each. Single-plane con-
focal images from the middle of cells that best reveal stress
granules did not always also capture optimal representation of
inclusion bodies and viral RNA in that cell (for example, at
12 h p.i.). Therefore, we also provided merge images for these
structures at the surface of the same cells (Fig. 7, sixth col-
umn).
DISCUSSION
These experiments show that inoculation of human cells
with RSV induces stress granules within 12 h of inoculation,
and the frequency of stress granules increases with the time
since inoculation. Although stress granule formation typically
is associated with translation inhibition, resulting in a poten-
tially antiviral state, the findings here show that impairment of
stress granule formation by G3BP knockdown reduces RSV
replication. In addition, the presence of stress granules was
associated with more robust viral protein expression on a per-
cell basis. Our data also suggest that even though RSV induces
stress granules and these structures contain many RNA bind-
ing proteins, the site of viral RNA production is in viral inclu-
sion bodies and not stress granules.
Following attachment and entry, RSV begins its life cycle
with gene transcription using an RNA-dependent viral RNA
FIG. 6. HuR protein colocalizes with RSV inclusion bodies but is not necessary for replication. (A) HEp-2 cells were infected with RSV
(MOI  1.0) for 24 h, fixed, and prepared for immunofluorescence. Anti-G3BP was used to mark stress granules and appears green in the merged
image. Anti-RSV P was used to mark RSV inclusion bodies and appears red in the merged image. HuR appears blue in the merged image. White
squares are used to mark areas in which HuR is contained in stress granules or inclusion bodies, respectively. The collapsed z-sections are shown
for each image. (B) Cells transduced with nontargeting (NonTgt) or HuR shRNA were compared with wild-type HEp-2 cells for expression levels
of HuR. Total HuR levels were quantified for each cell type and compared to wild-type levels. (C) Wild-type HEp-2 cells, cells treated with
nontargeting shRNA, or HuR-deficient cells were infected with RSV (MOI  0.1) for the indicated times. Viral RNA was collected and assayed
for the fold change in RNA levels during infection. (D) Wild-type or HuR-deficient cells were infected with RSV (MOI  0.1) for the indicated
times. Cell-associated virus and supernatant virus were collected at each time point. The viral titer for each sample was determined by plaque assay.
Error bars show standard deviations.
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polymerase. Following the accumulation of viral mRNAs and
proteins, the viral polymerase switches from a predominant
mode of transcription of mRNAs to replication of the viral
genome. Interestingly, our results indicate that stress granule
formation begins approximately when RSV initiates this
switch.
G3BP was first described as an essential stress granule as-
sembly protein through experiments that demonstrated that
the overexpression of G3BP results in the spontaneous forma-
tion of stress granules (37). In more recent studies, cells in
which G3BP expression was modestly reduced, by 30%, using
transient small interfering RNA, transfected cells were treated
with arsenite. In these experiments, large stress granules with-
out G3BP could be observed in some cells, while other cells
contained smaller and fewer stress granules (39). TIA-1 also
has been proposed to be an essential stress granule assembly
protein. Previous reports demonstrated that TIA-1 knockout
mouse embryo fibroblasts treated with arsenite displayed a
FIG. 7. Viral genomic RNA predominantly colocalizes with RSV inclusion bodies. HEp-2 cells were mock-infected or infected with RSV
(MOI  1) for the indicated times. RSV RNA-specific probes were added as described in Materials and Methods. Cells were fixed and processed
for immunofluorescence. Anti-RSV N was used as an inclusion body marker and appears green in the merged image. Anti-G3BP was used as a
stress granule marker and appears blue in the merged image. RSV RNA (vRNA) appears red in the merged image (fourth column). The main
images are xy cross sections, and the images above and to the left represent xz and yz cross sections, respectively. The horizontal lines are scale
bars, while the diagonal or vertical lines were used to calculate the intensity profiles. Intensity profiles at each time point demonstrate the strong
correlation between the N protein and viral genomic RNA (fifth column). Images of N (green), viral genomic RNA (red), and G3BP (blue) in mock
infection and at 1, 6, 12, and 24 h postinfection at an image plane near the cell surface are in the sixth column. PI, postinfection; a.u., absorbance units.
TABLE 1. RSV RNA is predominantly associated with viral
inclusion bodies
Pair of structures analyzed
% Colocalization at time (h)
postinfection
1 12 24
Viral RNA 	 inclusion bodies 87 96 91
Viral RNA 	 stress granules 0.0 2.2 4.5
Inclusion bodies 	 stress granules 0.0 1.6 3.4
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diminished capacity to form stress granules (11). It has been
proposed that these two proteins mediate stress granule for-
mation in similar ways, because both proteins bind mRNA and
both exhibit autoaggregation properties. Other stress granule
proteins, such as TIAR (11) and HuR (our studies), have been
knocked down but appear to have little effect on stress granule
formation. It should be noted that G3BP plays a role in other
cellular functions besides stress granule formation. G3BP has
been well characterized as a binding partner for Ras GTPase-
activating protein (RasGAP), a factor important in cellular
proliferation pathways (29). In addition, G3BP is known to be
an mRNA binding protein with an endoribonuclease function
(8, 38). Thus, knockdown of G3BP may have other unknown
consequences for viral replication independent of stress gran-
ule formation.
In addition to RSV, parainfluenza virus 5 and Sendai virus
are two other paramyxoviruses that are known to induce stress
granules (2, 12). In each case, stress granules were shown to be
present at relatively late time points after infection (18 to 24 h).
This finding is in contrast to results with other viruses, such as
poliovirus and Semliki Forest virus, that induce stress granules
early after infection but restrict stress granule assembly at later
time points (24, 39). Thus, it is possible that stress granule
formation enhances paramyxovirus replication during a por-
tion of the viral life cycle. Further evidence of this enhance-
ment comes from our results with G3BP-deficient cells. In
these cells, stress granule formation was impaired and, conse-
quently, viral replication was reduced. Other viruses, such as
West Nile virus and vaccinia virus, recruit specific proteins
involved in stress granule formation, such as TIA-1 and G3BP,
respectively, to viral replication factories (6, 13). Our results
show that neither TIA-1 nor G3BP associated with RSV RNA
and neither protein was recruited to RSV inclusion bodies,
which are the likely sites of viral replication.
HuR is a known mRNA binding protein thought to act as a
translation enhancer. The protein typically binds AU-rich re-
gions of the 3
 untranslated regions (UTR) of mRNAs and is
a known component of stress granules (16). In addition, HuR
has been shown to interact with elements of multiple viruses.
HuR was shown to bind to the 3
 UTR of HCV (35). Knock-
down of HuR resulted in a reduction of HCV replicon RNA
(20), indicating a potential role in HCV replication. Recently,
HuR was shown to interact with the HIV reverse transcriptase
protein (31). When HuR was knocked down, HIV reverse tran-
scription was impaired. Conversely, overexpression of HuR in-
creased HIV reverse transcription. In our studies, although we
observed HuR localization in viral inclusion bodies, knockdown
of HuR by up to 70% did not affect viral replication. It is thus
likely that HuR is not essential for RSV replication, or it is
possible that modest levels of this protein can maintain such a
role.
Interactions between viral RNA and stress granule proteins
have been described. Previous studies have shown that Sendai
virus RNA contains TIAR-binding sites, suggesting viral RNA
interaction with stress granule proteins (12). The West Nile
virus 3
-terminal stem-loop RNA binds TIA-1 and TIAR (22).
In addition, we recently showed that RSV RNA interacts tran-
siently with stress granules when infected cells are treated with
arsenite (33). In these studies, individual granules of RSV
RNA were observed to move into juxtaposition with stress
granules, dock, and then separate again. We observed similar
transient interactions between RSV RNA and stress granules
here; however, our data suggest that viral genomic RNA is
much more abundant in viral inclusion bodies.
A detailed understanding of the molecular mechanisms un-
derlying stress granule effects during viral infection is lacking.
In fact, evidence exists for both proviral and antiviral roles.
When TIA-1 knockout cells that exhibit impaired stress gran-
ule formation were infected with vesicular stomatitis virus or
Sindbis virus, both viruses grew to higher titers, indicating that
TIA-1 or, possibly, stress granules are restrictive to these vi-
ruses (22). However, infection of TIAR knockout cells with
West Nile virus resulted in decreased viral titers, suggesting a
proviral role for this protein. It is important to note, however,
that the functional role of stress granules in any sort of stress
condition is still not completely understood. Stress granules
have been proposed to be sites of mRNA sorting during peri-
ods of translation inhibition generated by a variety of stresses
(15). While multiple species of mRNA have been shown to be
associated with stress granules, this association appears to be
transient in nature (17, 19, 23). More recent studies have
suggested that mRNA cycles between the cytoplasm and stress
granules and that the vast majority of cellular mRNA remains
cytoplasmic, suggesting that these structures are neither a
holding nor a modification site for mRNAs (26).
Our studies suggest a functional role for stress granules
during RSV infection that enhances replication. Further ex-
periments will need to be carried out to determine the exact
mechanism of induction and the true role of these structures.
The identification of a specific function of stress granules dur-
ing viral infection could also elucidate a general function for
these structures in the normal cell life cycle.
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